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Physiological models of gas exchange in decision support of 
mechanical ventilation – prospective evaluation in an intensive care 
unit 
Abstract of thesis defended 27 November 2009 
Introduction: Management of mechanical ventilation is a complex process of finding 
the right balance between conflicting goals, where clinicians must make timely 
decisions in unfavorable circumstances. Minimal models of pulmonary gas exchange 
may be used at the bedside in the intensive care unit to help in this process providing a 
deeper understanding of the patient‟s gas exchange status. The aim of this PhD project 
was to build and evaluate minimal models of gas exchange, and prospectively 
evaluate a minimal model-based decision support system. 
Methods: Three retrospective studies were performed using data from various patient 
types including intensive care patients: comparing a hypoxemia index and model of 
O2 gas exchange available in clinical practice with a two parameter minimal model; 
evaluating a decision support system for suggestions of inspired O2 fraction; and 
investigating three minimal models of varying complexity for their ability to describe 
gas exchange of both O2 and CO2. A prospective study was performed in an intensive 
care unit to compare decision support system suggestions of inspired O2 and resulting 
oxygenation with those selected by attending clinicians. 
Results: The often used hypoxemia index, PaO2/FiO2 ratio, varies significantly with 
changes in inspired O2, a common change in therapy. The clinically available shunt 
only model of gas exchange can not accurately describe this variation, a two 
parameter minimal model describing shunt and ventilation-perfusion mismatch can. 
The decision support system provides appropriate suggestions of inspired O2 fraction 
retrospectively, and prospectively. A three parameter minimal modeling complexity is 
necessary for an accurate description of gas exchange of both O2 and CO2. 
Conclusions: A minimal model-based decision support system can be used to provide 
a deeper understanding of the individual patient‟s gas exchange status, and to provide 
appropriate suggestions on inspired O2 fraction freeing the focus of clinicians for 
more challenging therapies. 
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Abbreviations and symbols 
In the thesis, most measurements and model variables are written as a main symbol 
followed by a modifier and substance, e.g. PaCO2 for partial pressure of carbon 
dioxide in arterial blood, or with no specific substance, e.g. AV  for alveolar 
ventilation. Hemoglobins are not defined for specific blood components and are 
specified without a modifier, e.g. CHb for Hemoglobin concentration in blood.   
 
Main symbols 
F Gas fraction  Q Cardiac output 
P Gas pressure  V  Ventilation 
C Concentration  V Volume  
S Saturation    
 
Modifiers 
A Alveolar Dana Anatomical dead space 
i Inspired a Arterial 
et End-tidal mv Mixed venous 
c Capillary p Pulse oximetry 
t Tidal m Model predicted 
 
Substance 
O2 Oxygen CO2 Carbon dioxide 
Hb Hemoglobin MetHb Met-hemoglobin 
COHb Carboxy-hemoglobin   
 
Other abbreviations and symbols 
ΔPO2 
 
O2 pressure drop from alveolar 
air to lung-capillary blood 
A/QV  
 
Alveolar ventilation/perfusion 
ratio 
DSS Decision support system DPG 2,3-diphosphoglycerate 
PEEP Positive end-expiratory pressure VILI Ventilator Induced Lung Injury 
ICU 
f 
Intensive Care Unit 
Respiratory frequency 
MIGET Multiple inert gas elimination 
technique 
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… modelling is assuming a more prominent role in mainstream 
anaesthesia and critical care research, becoming an accepted 
methodology and an ever-more useful part of the research 
process. 
... Modelling runs through all of our endeavours, and we stand 
to benefit hugely by becoming acquainted with this powerful 
device. 
J. G. Hardman and J. J. Ross 
Editorial in British Journal of Anaesthesia 2006 
Vol 97, pages 589-92 
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1. Clinical and technical background of the project 
1.1 Introduction 
Mechanical ventilation is a life-sustaining therapy used to secure sufficient 
oxygenation and carbon dioxide elimination and spare patients‟ energy allowing them 
to cope with underlying diseases and recover from surgery or trauma. Managing 
mechanical ventilator settings for ventilator therapy of the common postoperative 
patient is generally a simple task mainly comprised of weaning the patient from 
ventilator support, i.e. stepwise reduction in ventilator support until the patient alone 
is driving ventilation. However, in critically ill patients presenting in the intensive 
care unit (ICU), with failure of one or more organ systems often including the lungs, 
managing mechanical ventilation is a complex task. In these patients, selecting the 
appropriate ventilator settings can be considered as a search for the optimal 
compromise of conflicting goals. Such a search would preferably be performed based 
on a good understanding of the patient‟s lung function. However, this is often difficult 
using the vast number of relatively simple measurements currently available in the 
ICU. Mathematical models of pulmonary gas exchange may be used to integrate 
simple measurements and provide a deeper understanding of the patient‟s underlying 
physiology and pathophysiology. Implementing such models in decision support 
systems (DSSs) to calculate suggestions on therapy and provide physiological 
understanding may provide a valuable tool for clinicians, when deciding on 
appropriate therapy. 
 
To illustrate the need for DSSs in mechanical ventilation, section 1.2 will present the 
clinical background of the project. The syndromes acute lung injury and acute 
respiratory distress syndrome are introduced. Ventilator induced lung injury (VILI) 
will be presented constituting the background of recent approaches to mechanical 
ventilation, termed lung protective ventilator strategies. Recent studies on ventilator 
strategies will also be introduced illustrating the lack of consensus on how to properly 
mechanically ventilate patients with severe lung disorders. In section 1.3 the literature 
on decision support systems is reviewed covering rule-based systems representing the 
most prevalent type of DSS, and model-based DSS. The focus of this PhD is decision 
support of mechanical ventilation using models of pulmonary gas exchange. Model-
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based DSSs require physiological models which can predict the response of the 
individual patient to changes in therapy and preferably also provide the clinician with 
a deeper understanding of the lung status of the patient. Section 1.4 contains a review 
of currently available measurements and models of pulmonary gas exchange in 
clinical practice, the reference technique for measurement of pulmonary gas exchange 
and finally „minimal‟ models of gas exchange, which represent compromises between 
the oversimplified models in clinical practice and the complex techniques used in the 
pulmonary laboratory. The scientific and clinical questions which have formed the 
aims of this PhD project are stated in section 1.5. 
1.2 Managing mechanical ventilation in the ICU 
Acute lung injury and the acute respiratory distress syndrome 
Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are 
syndromes of inflammation and increased permeability with significantly impaired 
lung function, the only difference between the syndromes being a more severe degree 
of hypoxemia in ARDS patients.  
 
In 1994, Bernard and co-authors published a now generally accepted definition of the 
syndromes [1]: 
 Acute onset 
 Hypoxemia 
o ALI: PaO2/FiO2 ≤ 300 mm Hg (40 kPa) regardless of PEEP level 
o ARDS: PaO2/FiO2 ≤ 200 mm Hg (27 kPa) regardless of PEEP level 
 Bilateral infiltrates seen on frontal chest radiograph 
 Pulmonary artery wedge pressure ≤ 18 mm Hg or no clinical evidence of left 
atrial hypertension 
 
The incidence of ALI and ARDS in Denmark were reported in 2000 to be 17.8 and 
14.6 patients per 100000/year, respectively [2], with 90-day mortalities being 47.3 % 
and 46.5 %, respectively [2]. A later European study reported that 7 % of all patients 
admitted to an ICU and 15 % of patients mechanically ventilated for at least 24 hours 
had or developed ALI/ARDS [3]. This study reported hospital mortalities in ALI and 
ARDS patients of 32.7 % and 57.9 %, respectively.  
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The lung damage seen in lungs of patients with ALI/ARDS is heterogeneously 
distributed with alveolar collapse and alveolar over-distension seen in different 
regions of the lungs [4]. Collapse is mostly reported to occur in dependent regions 
whilst over-distension is seen in the non-dependent regions, often referred to as the 
baby-lung of ALI/ARDS [4,5]. The severity and spread of lung damage increases the 
need for aggressive ventilator support such as high levels of inspired oxygen (FiO2) 
and high pressures and volumes but at the same time also increases the risk for 
ventilator induced lung injury (VILI). For example, increases in pressure and volume 
may act to open collapsed alveoli improving gas exchange in some regions whilst 
further over-distending alveoli in other lung regions causing lung damage.  
Ventilator induced lung injury 
The fact that mechanical ventilation may cause damage to the patient‟s lungs is not 
new and was discussed as early as in the 1700s [6]. However, over the last decades 
the topic has received increasing attention with the realization that other damaging 
mechanisms exist besides air leaks due to rupture of the airspace wall caused by high 
pressures (barotrauma) [7,8]. Studies of lungs from animals and patients who have 
undergone ventilator therapy with large pressures and volumes have shown lung 
tissue damage such as interstitial fibrosis, hyaline membranes and alveolar edema 
[8,9].  
In addition, the major cause of death of ALI/ARDS patients has been found not to be 
hypoxemia but multiple organ failure [3,10]. Several authors have suggested that VILI 
has an important role in the pathology of multiple system organ failure due to 
hypoxia, release of inflammatory mediators (biotrauma), and spillover of these 
mediators and bacteria to the blood due to increased alveolar and microvascular 
permeability [11-12].  
 
Biotrauma has been shown in relation to injurious mechanical ventilation in both 
animals and patients [8, 13-15] but not all results have been consistent [16]. Two 
mechanisms, termed volutrauma and atelectrauma, have been suggested as causes of 
tissue damage, biotrauma and increased alveolar and microvascular permeability. 
Overdistension of lung tissue due to high volumes and/or pressures (volutrauma) 
occurs, in particular, in the baby-lung of ARDS where tidal volumes considered 
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normal in healthy lungs are deleterious [5]. Repeated recruitment and de-recruitment 
of atelectic lung regions (atelectrauma) has been suggested to cause stress and strain 
in the junctions between adjacent alveoli [8,17]. The physical stress and strain 
involved in volutrauma and atelectrauma may lead to epithelial damage and increased 
alveolar and microvascular permeability causing pulmonary edema [8]. Volutrauma 
and atelectrauma may also impair the function of pulmonary surfactant [18]. 
Surfactant is a chemical compound which acts on the air/water interface inside the 
alveolar epithelium to reduce surface tension lowering work of breathing, maintaining 
fluid balance across the alveolar membrane and preventing alveolar collapse [18].  
 
High fractions of oxygen in the inspired air (FiO2) can also affect lung status leading 
to gas-exchange impairment or tissue damage. High levels of FiO2 can cause 
atelectasis in regions with low ventilation/perfusion ratios [19-21] and cause toxic 
effects [22-23].  
Lung-protective ventilator strategies 
The role of mechanical ventilation as a major cause of patient mortality has spurred 
numerous experimental investigations and clinical trials addressing how to properly 
manage mechanical ventilation, in particular in ALI/ARDS patients. In the following, 
some of the major studies within lung-protective ventilation are described. 
 
In 1998, Amato and coworkers described a statistically significant improvement in 
28-day mortality in 53 ARDS patients by using a strategy consisting of: recruitment 
maneuvers i.e. short periods of large pressures to open atelectic lung regions; positive 
end expiratory pressure (PEEP) to keep recruited alveoli open; and small tidal 
volumes to reduce lung tissue stress [24]. After 28 days the mortality of the lung 
protective group was 38 % compared to 71 % in the conventionally treated group. 
However, several studies with similar strategies and number of patients did not find 
significant differences in mortality between low and high tidal volumes [25-27].  
 
A large multicenter study conducted by the Acute Respiratory Distress Syndrome 
Network (ARDSNet) followed the trial by Amato et al. comparing the use of small 
and large tidal volumes [28]. This study showed that a strategy comprising tidal 
volumes small (Vt = 6 ml/kg) in comparison to previously common tidal volumes and 
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peak inspiratory pressures less than 30 cmH2O resulted in improved mortality 
compared to large tidal volumes (Vt = 12 ml/kg) and peak inspiratory pressures less 
than 50 cmH2O.  
 
A later study conducted by the ARDSNet investigated the use of low versus high 
PEEP, maintaining a Vt of 6 ml/kg in both groups [29]. The study did not find any 
significant difference in mortality between the two groups. However, later analysis 
has indicated that this study might not have had large enough differences in PEEP 
levels between the two groups to demonstrate a significant difference in mortality 
[18].  
 
Larger differences between PEEP levels in two patient groups (13.4 ±2.6 cmH2O in 
53 patients vs. 9.8 ± 2.8 cmH2O in 50 patients) were reported in a recent study to 
produce significant improvement in mortality [30]. However, the two groups were 
ventilated with different tidal volumes preventing the authors from drawing 
conclusions on the importance of PEEP levels on mortality [30]. In addition, two 
recently published multicenter trials compared two groups with equal low tidal 
volumes but with lower and higher PEEP levels [31,32]. Neither of these two studies 
could demonstrate significant differences in mortality between the studied patient 
groups.  
 
The focus of current ventilator strategies is on preventing VILI by lowering volumes 
and pressures. However, FiO2 should not be increased indiscriminately to secure 
oxygenation [19-23], and several authors have pointed out that low tidal volumes may 
lead to low ventilation/perfusion ( A/QV ) regions in the lungs, which limits gas 
exchange and are highly susceptible to adsorption atelectasis due to hyperoxia 
[33,34]. Although not the focus of recent debate, the vast majority of clinical trials 
have included limitation of FiO2 either directly or through goals for oxygenation in 
their ventilator strategies [15, 24-29, 31,32]. 
 
Whilst there is a general consensus that the lungs should be ventilated with caution, 
there is also a general consensus that the understanding of the different types of lung 
damage and the mechanisms involved is not complete [16-18,33-35]. Furthermore the 
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varying results from clinical trials indicate that the perfect ventilation strategy, if there 
is such a thing, has yet to be found. It has been speculated, that the heterogeneity of 
ALI/ARDS patients requires that every patient should be treated on an individual 
basis [17], which is supported by recent clinical studies [36,37]  
 
This leaves intensive care clinicians with a far from straightforward task, which needs 
to be performed in a timely manner, based on interpretation of large amounts of data. 
The increasing complexity and available options on modern ventilators do not help to 
alleviate the problem. These circumstances work against human nature. The human 
brain can process a limited amount of information when making decisions [38], which 
combined with the stressful environment of the ICU have been suggested as 
augmenting factors for errors committed by health care professionals in the ICU [39, 
40]. These points illustrate that DSS for mechanical ventilation may be beneficial.  
1.3 Decision support systems for mechanical ventilation 
Decision support systems (DSSs) may be categorized with regards to several aspects: 
open or closed loop; approach to data integration and analysis; approach to decisions, 
e.g. rule-based, utility theory, etc.; and the settings optimized by the system. In the 
following, the literature is reviewed categorizing published DSS for mechanical 
ventilation into rule-based systems and model-based systems. Rule-based systems will 
refer to systems that are mimicking experts in the field or clinical guidelines 
performing data integration and analysis using the clinical measurements directly 
without physiological models.  
Rule-based systems 
The vast majority of developed DSS for ventilator management have been rule-based 
systems [41-63]. These systems have often been developed for specific subproblems 
of ventilator management such as weaning patients from mechanical ventilation [49]. 
 
Figure 1 shows the general overall structure of such systems. Rule-based systems 
typically include 4 overall components: data input; data integration and analysis; rule 
base; and decision control (often also called inference engine). The interaction and 
integration of these components may vary from system to system. Data input can 
consist of ventilator settings, lung mechanic measurements, gas exchange 
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measurements, metabolic measurements, hemodynamic measurements and patient 
characteristics such as height, diagnosis etc. These data may be automatically 
retrieved from the ventilator and monitoring devices, or typed in manually by the 
clinician, or both. The role of the data integration and analysis component varies from 
system to system but may be comprised of tasks such as data validation and 
classification e.g. removal of noise, and temporal data analysis. The rule base 
comprises the built-in rules of the system, e.g. IF-THEN-ELSE descriptions linking 
patient physiological data with system response. The decision control component 
selects the advice to provide to the clinician. 
 
If the DSS is an open-loop system the clinician manually sets the ventilator settings 
according to the suggestions provided by the DSS. In a closed-loop system the DSS 
automatically adjusts the ventilator settings. Irrespectively, rule-based systems have in 
common that they are black-box systems, i.e. the clinician is not aware of the 
considerations involved in the suggestions provided by the systems. 
 
 
 
Figure 1: The general structure of a rule-based decision support system for ventilator 
management. 
 
Strict rule-based systems i.e. comprised of IF-THEN-ELSE rules are predominating 
[41-58].  In the simplest form these are relatively easy to implement and constitute 
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electronic versions of paper based clinical guidelines [e.g. 45-48]. Almost all 
published DSS based on this simple structure have been prospectively evaluated [41-
53]. Two of these studies have been large multicenter randomized trials [48, 53]. The 
study reported by East et al. investigated a clinical guideline for managing ARDS 
patients, and although the implemented clinical guideline did not result in statistically 
significant improvement in mortality, the study demonstrated the feasibility of 
implementing a DSS across several institutions [48]. The study by Lellouche et al. 
compared weaning of patients using a closed-loop DSS (GANESH) [49] with 
weaning using written clinical guidelines [53]. The patient group weaned using 
GANESH had lower duration of weaning, shorter duration of mechanical ventilation 
and shorter ICU stay [53]. GANESH has also been implemented as part of a 
commercial system, termed SmartCare
TM
/PS by Dräger Medical [64].  
 
Adaptive support ventilation (ASV) is another commercially available closed loop 
DSS, implemented in Hamilton ventilators [65]. When using ASV the clinician 
defines a desired minute volume and the system automatically adjusts respiratory 
frequency, tidal volume and inspiratory pressure and switches between support and 
control behavior using rules according to measurements of the patient‟s lung 
mechanics [65]. Several studies have been performed using ASV, for example a 
multicenter study comparing ASV with controlled ventilator modes in patients with 
acute respiratory failure [66]. The study showed that ASV could maintain similar 
PaCO2 as clinicians but with lower peak airway pressures.  
 
In addition to SmartCare
TM
 and ASV several advanced ventilator modes have been 
developed which have elements in common with DSS. Most notable are proportional 
assist ventilation (PAV), and neurally adjusted ventilatory assistance (NAVA) which 
can be considered advanced versions of the pressure support mode. These systems 
determine the level of pressure support using a gain factor adjusted by the clinician 
combined with either measured inspiratory flow (PAV) or the electromyographic 
activity from the diaphragm (NAVA) [67].  
 
Different research groups have taken alternative approaches to capture the heuristics 
of critical care experts [59-63]. These approaches include knowledge bases using 
automated knowledge acquisition [59], and fuzzy logic for temporal data 
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classification [60, 63], to derive the rule base [62], and to mimic human decision-
making [61]. One of these systems have been implemented and prospectively 
evaluated in 7 neonates showing agreement between clinicians and provided advice in 
more than 90% of cases [63]. 
 
The black-box approach shared by all the presented rule-based DSS is also one of the 
major weaknesses of these systems, as they do not provide the clinician with a deeper 
understanding of the individual patient‟s status. If changes in settings alter the status 
of the patients this may require reevaluations leading to new changes. As such, the 
rule-based systems may require a trial and error approach. Model-based DSS may 
solve both of these problems. Parameters of physiological models may provide a 
deeper physiological understanding of the patient. In addition, once model parameters 
have been tuned to fit the individual patient data, models can predict patient response 
to changes in ventilator settings allowing the clinician quick evaluation of therapy 
changes, thereby eliminating the need for the trial and error approach [68]. 
Model-based decision support in ventilator management 
Figure 2 shows the overall general structure of model-based DSS in ventilator 
management. Five overall components are generally included: data input; 
physiological models; parameter identification; model prediction; and decision 
control. The data input component is conceptually identical to that of the rule-based 
systems. The physiological model component constitutes the physiological models 
used in a model-based DSS such as models of pulmonary gas exchange. Parameter 
estimation often constitutes measurement of patient response to small variations in 
therapy to allow tuning of model parameters to fit the physiological models to the 
individual patient. This process can be manual with the system interacting with the 
user during the process or it can be automated. Parameter estimation will often 
encompass the data integration in the system. Once fitted to patient data the models 
can be used to simulate patient response to changes in therapy, e.g. changes in 
oxygenation upon changes in inspired oxygen fraction. This can involve the clinician, 
by letting the clinician test different changes in settings without involving the patient 
or it can be done by the DSS to calculate optimal therapy. This can be performed by a 
decision control component using mathematical functions associating different 
strategies with corresponding utilities, i.e. models of clinical preferences. Hybrid 
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systems have also been developed where physiological models are combined with a 
rule base to decide suggestions on therapy.  
 
 
Figure 2: General structure of model-based decision support systems for ventilator management. 
 
Model-based DSSs may solve two problems, i.e. providing a deeper understanding of 
patient physiology and preventing trial and error approach to ventilator management. 
However, they may also introduce two overall limitations. When physiological 
models are integrated into the calculation of new advice, model-based DSS depend on 
the implemented models to accurately predict patient response to changes in ventilator 
settings. In addition, in order to allow patient specific predictions, the model 
parameters must be tuned to fit patient specific data before suggestions on therapy can 
be calculated, and this may be a time-demanding process. These limitations have been 
dealt with in different ways by the different model-based DSS [69-74]. 
 
The first reported DSS using physiological models was the open-loop system 
OPTPROG [69]. OPTPROG found the combination of respiratory frequency (f), tidal 
volume (Vt) and PEEP which resulted in the minimal peak respiratory power (PRP), 
which was defined as an index of lung trauma. The system also maintained PaO2 and 
PaCO2 within limits defined by a clinician. OPTPROG was prospectively evaluated in 
5 patients with various pulmonary diseases and 7 post operative coronary artery 
bypass graft patients showing that the system was able to minimize PRP whilst 
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maintaining adequate PaO2 and PaCO2 values [69, 70]. However, OPTPROG had a 
couple of significant limitations. OPTPROG was based on linear programming, and 
the model parameters had no physiological interpretation [68]. As such, the system 
did not provide clinicians with a deeper physiological understanding of the patient. In 
addition, estimation of model parameters required a time-demanding experiment 
taking approximately one hour involving frequent sampling of arterial blood beyond 
that of routine clinical practice [68]. 
 
The VentPlan system [71] used a model of pulmonary gas exchange to provide open-
loop decision support of FiO2, Vt and f. The implemented model was a classical three 
compartment model with model parameters having physiological interpretations [75]. 
The model includes two parameters: a shunt parameter which quantifies the fraction 
of pulmonary perfusion not reaching ventilated alveoli; and a parameter describing the 
amount of physiological dead space, i.e. the amount of ventilation not participating in 
gas exchange. Parameter estimation was performed as a combination of a Bayesian 
belief network and patient specific measurements [71]. The belief network was 
implemented to enable parameter estimation in cases when measurement data were 
insufficient to allow a unique numerical solution when estimating model parameters. 
Advice was calculated based on a combination of model simulations and utility theory 
[76], using penalty functions to model clinical preferences. VentPlan was 
retrospectively evaluated using data from 10 ICU patients indicating potential of the 
system [71]. However, to the best of my knowledge, VentPlan development stopped 
before any prospective evaluation could be performed. 
 
The Sheffield Intelligent Ventilator Advisor (SIVA) uses a physiological model 
describing the same factors as that of VentPlan, i.e. shunt and physiological dead 
space [72]. SIVA uses the ratio between the alveolar-arterial oxygen difference to 
PaO2 (PA-aO2 / PaO2) as an input to an Adaptive-Network-based Fuzzy-Inference 
System [62] to estimate the shunt parameter. To estimate the physiological dead space 
the system requires invasive measurement data using a pulmonary artery catheter and 
a numerical method, which the authors report has often convergence problems [72]. 
Alternatively physiological dead space could be estimated by the clinician. SIVA is a 
hybrid system and uses fuzzy rule-bases in combination with models to provide open-
loop decision support of FiO2, PEEP, inspiratory pressure (Pinsp) and f, although 
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without modeling the effect of PEEP. Evaluations of SIVA have so far been limited to 
simulation studies [72]. 
 
The open-loop system INVENT presented by Rees et al. uses a two parameter 
physiological model of gas exchange in combination with a model of the acid-base 
chemistry of blood as well as a simple model of lung mechanics [73]. The gas 
exchange model describes shunt and ventilation/perfusion mismatch, the two major 
factors affecting pulmonary gas exchange in patients with respiratory failure [77]. The 
parameters of the gas exchange model are estimated using a method comprised of 
varying inspired oxygen fraction in 4-6 steps and measuring the oxygen contents of 
the expired gas as well as pulse oximetry oxygen saturation (SpO2), this process 
taking approximately 10-15 minutes [78]. The lung mechanics model requires input of 
PEEP and respiratory compliance and the blood model and the gas exchange model 
also require a single arterial blood gas measurement. The INVENT system provides 
advice on FiO2, Vt and f using utility theory in the form of penalty functions 
combined with the three models [73]. At the beginning of this PhD project evaluations 
of the system had not been published. 
 
The most recently introduced model-based DSS is the FLEX hybrid system, which 
can act both as an open-loop and a closed-loop system [74]. The approach of the 
FLEX system has similarities to the OPTPROG system with the implemented models 
being empirical by nature and mainly using model parameters without physiological 
interpretation. FLEX incorporates a large number of these simple models in 
combination with a rule base to calculate suggested levels of FiO2, PEEP, f, I:E-ratio, 
PIP, and Vt as well as to wean patients [74]. In this process the system aims at 
minimizing the work of breathing using a modified version of an empirically derived 
equation [79]. The FLEX system does not require any parameter estimation 
procedures, but use readily available measurement data or parameters which are not 
fitted to the individual patient. So far, the system has been limited to retrospective 
evaluations, showing the suggestions of the system to be in general agreement with 
decisions taken by clinicians in ICU patients [74] and neonates [80].  
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1.4 Mathematical models of gas exchange 
Measurements and models available in clinical practice 
Several measurements are available in clinical practice which may provide some 
information regarding the gas exchange status of a patient. For oxygenation, 
measurement of arterial blood gases yields arterial partial pressure of O2 (PaO2) and 
arterial oxygen saturation (SaO2). An arterial blood sample can also be analyzed to 
measure hemoglobins (Hb, MetHb and COhb) providing information regarding the 
oxygen carrying capacity of the blood. Hemoglobin concentration, PaO2 and SaO2 can 
also be used to calculate the total contents of O2 in arterial blood. Oxygen 
concentrations and pressures can also be obtained from samples of central or mixed 
venous blood, yielding information regarding the use of oxygen by the organs and 
peripheral tissues, i.e. the general ischemic status of the body. Mixed and central 
venous blood samples, however, require catheters in the pulmonary artery or one of 
the larger veins (e.g. the internal jugular vein), respectively, and are not part of routine 
clinical care in all ICUs. These measurements need to be related to the ventilation and 
FiO2 to be interpreted with regards to the lung status of the patient. 
 
A range of oxygen tension based indices have been developed to aid in interpretation 
of oxygenation with regards to ventilator settings. The ratio between oxygen partial 
pressure in arterial blood to FiO2 (PaO2/FiO2) is probably the most common index of 
hypoxemia, especially in clinical studies, and is part of the definition of ALI/ARDS. 
Another frequently used tension based index is the alveolar-arterial oxygen partial 
pressure difference (PA-aO2) [81]. This index provides an estimate of the total drop in 
oxygen partial pressure through the pulmonary system. However, the index requires 
calculation of the alveolar partial pressure of oxygen (PAO2) using the alveolar air 
equation requiring measurement of, or an assumed value of the respiratory quotient 
[81]. All these oxygenation measures and indices vary with one or more 
extrapulmonary factors such as ventilation and variation in FiO2 which are common 
therapeutic interventions in mechanically ventilated patients and affect oxygenation 
but not the underlying physiology or pathophysiology of the patient [77,]. 
 
The standard method for evaluating pulmonary gas exchange of CO2 is to measure the 
partial pressure of CO2 in arterial blood (PaCO2). In addition, capnography can be 
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used to evaluate the CO2 contents in the expired gas in relation to either time or 
expired volume, although this is not commonly applied in the ICU [83]. Capnography 
allows measurement of end-tidal partial pressure or fraction of CO2 (PetCO2 or 
FetCO2). When both PetCO2 and PaCO2 are available it is possible to calculate the 
PetCO2-PaCO2 difference which will increase with A/QV  mismatching and to a 
lesser degree venous admixture [84]. The anatomical and alveolar dead space volumes 
can also be calculated from the capnogram, the latter if a PaCO2 measurement is 
available. Alternatively the physiological dead space can be calculated using 
Enghoff‟s modification of the Bohr equation [85] requiring PaCO2 and measurement 
or calculation of the partial pressure of CO2 in the mixed expired gas.  
 
The current state of the art for quantifying pulmonary gas exchange in clinical 
practice is measurement of intrapulmonary shunt [81]. When measured at an FiO2 less 
than 100% the value is termed venous admixture and describes the patient‟s 
pulmonary gas exchange abnormality as due to alveoli being perfused but not 
ventilated. It has been shown that the measurement of intrapulmonary shunt is 
inadequate to describe changes in oxygenation with variation in FiO2, and that it is 
necessary to separate oxygenation problems into that caused by pulmonary shunt and 
that due to an alveolar-lung capillary drop in partial pressure of oxygen [86-88]. By 
measuring intrapulmonary shunt at FiO2=100%, the intrapulmonary shunt can be 
measured without the effects of an alveolar-lung capillary drop in partial pressure of 
oxygen. However, inspiration of pure oxygen may cause absorption atelectasis 
thereby giving an overestimate of the true shunt value [19,89] and the method still 
gives no information regarding the presence of an alveolar-lung capillary drop in 
partial pressure of oxygen, such as due to A/QV  mismatching in the lungs. 
The Multiple Inert Gas Elimination Technique 
To appreciate the concept of minimal modeling and the compromises made, one 
should first look at the current reference technique for quantifying gas exchange in the 
pulmonary laboratory, which is the multiple inert gas elimination technique (MIGET) 
[90]. MIGET relies on measurement of retention and excretion of 6 inert gases 
sampling blood and expired gas data. MIGET uses a model of pulmonary gas 
exchange comprised of 50 compartments with different A/QV  relationships 
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accounting for an alveolar-lung capillary drop in partial pressure of oxygen. The 
model also includes shunt being the one extreme of the A/QV  range ( A/QV  = 0) and 
alveolar dead space being the other extreme ( A/QV  = ∞). This model is fitted to the 
retention and excretion data and the end result is reported as distributions of blood 
flow and ventilation across the compartments of the model.  
 
Use of the MIGET technique in the pulmonary laboratory has contributed 
significantly to the current physiological understanding of pulmonary gas exchange in 
healthy subjects at different age [91], during anesthesia [92], in chronic obstructive 
pulmonary disease [89] and in patients with acute respiratory failure including ALI 
and ARDS [94]. MIGET studies have shown that lungs of ARDS patients are 
characterized by large fractions of shunt and in many patients there are lung regions 
with low A/QV  ratios and/or large fractions of ventilation going to alveolar dead 
space [94, 95]. The A/QV  distributions produced by MIGET have also been shown to 
describe the effects of various changes in therapy on pulmonary gas exchange [94]. In 
ALI/ARDS patients, for example, increases in PEEP as well as changes in posture 
from supine to prone have been shown to reduce shunt [95-98]. In addition, 
inspiration of 100 % O2 has been shown to convert units with low A/QV  into shunt 
[94] possibly due to absorption atelectasis [19, 33-34]. 
 
The MIGET experimental procedure is highly complex and involves preparing and 
infusing the inert gases, sampling of blood and expired gases and analyzing these 
using gas chromatography [90], the technique is therefore inappropriate for routine 
clinical application. 
Minimal modeling of pulmonary gas exchange 
In the past 15 years a considerable effort has been made to formulate minimal models 
based on few model compartments and parameters which can be estimated from 
routine clinical data. As originally suggested by Riley et al [86,87] and King et al. 
[88] these models describe pulmonary gas exchange abnormalities as caused by 
intrapulmonary shunt combined with an alveolar-lung capillary drop in partial 
pressure of oxygen. The latter factor has been modeled either using one [99-101] or 
two compartments to describe A/QV  mismatch [78,102-104], one compartment with 
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diffusion limitation [102,105,106], or two compartments to describe both A/QV  
mismatch and diffusion limitation [107,108]. These models are poor descriptions of 
physiology compared to the 50 compartment model of MIGET but significant 
improvements compared to measurement of intrapulmonary shunt or dead space 
volume alone.  
 
Minimal models describing intrapulmonary shunt and an alveolar-lung capillary drop 
in partial pressure of oxygen have been shown to fit oxygenation data from normal 
subjects [99,103,106-108]; patients before [99,100,102,103], during [99-101] and 
after [99,100,102-104,106] major surgery; patients presenting in intensive care [103]; 
patients with chronic obstructive pulmonary disease (COPD) [107,108]; patients with 
incompensated heart failure studied before and after diuretic therapy [103]; and 
anesthetized mechanically ventilated dogs with acutely applied hypoxia or with 
induced intense small airway constriction in a rebreathing model of COPD [108].  
 
The model describing intrapulmonary shunt and A/QV  mismatch presented by 
Kjærgaard et al. [102], which is the model used in INVENT, has also been shown to 
fit retention and excretion data comparable to MIGET in pigs before and after lung 
damage caused by oleic acid infusion [109]. Additionally the model presented by 
Vidal Melo and co-workers [107] has been shown to produce A/QV  distributions 
having positive correlations with MIGET A/QV  distributions in COPD patients and 
healthy subjects before and after exercise [108]. However, at present only a single 
model has been evaluated for its ability to describe gas transport of CO2 [107,108]. 
1.5 Aims of the project 
Management of mechanical ventilation in patients with severe lung disorders 
constitutes a process of balancing conflicting therapeutic goals. This is a complex task 
which clinicians in the ICU must perform based on numerous measurements in a 
stressful environment and with no clear evidence based strategies for several of the 
ventilator settings. Several DSSs have been developed to aid the clinician in this 
process. The majority of these systems have been rule-based DSSs, which may 
provide sound advice, but do not provide the clinician with a deeper understanding of 
the individual patient. Rule-based DSSs may also require a time demanding trial and 
 25 
error approach as commonly used in clinical practice to find the appropriate settings. 
Model-based DSS may provide a more appropriate alternative. When models are 
tuned to fit patient data they may provide a deeper physiological understanding of the 
patient and predict patient responses to changes in therapy, thereby removing the need 
for trial and error. However, this requires models with parameters having 
physiological interpretation and which may be identified from routine clinical data. 
Measurements and models of pulmonary gas exchange currently available in clinical 
practice are oversimplified. In contrast the reference technique, the MIGET, is too 
complex to use in clinical practice. Minimal models have also been developed 
presenting compromises between feasibility and complexity. This PhD project has 
addressed the use of such minimal models to describe gas exchange in the ICU and 
their use in a DSS, through investigation of the following questions:   
 
 How well do the current dominating oxygenation index (PaO2/FiO2 ratio) and 
gas exchange model (shunt model) used in clinical practice describe 
oxygenation in comparison with a two parameter minimal model of O2 gas 
exchange describing both shunt and ventilation/perfusion mismatch? (Paper I) 
 
 Can INVENT based on a two parameter model of gas exchange describing 
shunt and ventilation/perfusion mismatch combined with utility theory provide 
appropriate suggestions on FiO2 when evaluated retrospectively in intensive 
care patients? (Paper II) 
 
 Can INVENT manage FiO2 in intensive care patients when evaluated 
prospectively? (Paper III) 
 
 A model describing gas exchange of both O2 and CO2 is necessary for 
INVENT to provide suggestions of Vt and f in addition to FiO2. What 
complexity is necessary for a minimal model representation of pulmonary gas 
exchange of both O2 and CO2? (Paper IV) 
 
To address these questions technical methods were developed and refined. These 
tasks involved modeling of pulmonary gas exchange, methods for estimation of model 
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parameters, development of a version of INVENT used with a database system to 
provide suggestions on FiO2. The technical solutions were similar between studies, 
but were adapted for the specific applications. The following chapter presents the 
technical methods used during the project, and the tailoring of the methods for the 
specific studies. 
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2. Gas exchange models and decision support system 
This chapter describes the technical methods used to answer the four questions 
addressed in the PhD project. The project has evolved around minimal models of 
pulmonary gas exchange. Models of different complexity have been used in the 
studies, but all models have followed the same overall structure. The models are 
presented in section 2.1. Methods used for estimation of model parameters have been 
adapted to the individual studies depending on available measurement data and aims 
of the studies, the different approaches are explained in section 2.2. Section 2.3 
presents the version of the DSS, INVENT, developed to provide suggestions on FiO2. 
The system is integrated in a database system, ICARE, which is described briefly in 
section 2.4. 
2.1 Minimal models of pulmonary gas exchange 
All four studies were performed using physiological models with the same structure 
as the two parameter model originally presented by Kjærgaard et al [102]. These 
models are based on conservation of mass, continuous breathing and perfusion and 
assume steady state. 
Figure 3 shows the overall structure shared by these models, indicating the model 
parameters in bold. In addition to the shown compartments all models used in the 
study have a serial dead space compartment. The model presented by Kjærgaard et al. 
has a shunt parameter (fs) describing the fraction of pulmonary perfusion not reaching 
ventilated alveoli. In addition the model has two ventilated and perfused 
compartments. The perfusion is locked at a specific distribution defined by the f2 
parameter such that one parameter receives 90 % of non-shunted blood flow and the 
other 10 % (f2=0.9). Distribution of ventilation varies between the two compartments 
as defined by the fA2 parameter, such that a fA2 of 0.9 would result in optimal A/QV  
matching, whereas fA2 less than 0.9 would signify A/QV  mismatching. This two-
parameter model (fs and fA2) is used in all four studies, and is the model used in 
INVENT for predicting patient response to changes in FiO2 in papers II and III. 
 
In paper I, the two parameter model is compared with the „effective‟ shunt model, 
which is a one-parameter model having a shunt compartment, and where non-shunted 
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blood flow goes to a ventilated compartment receiving all alveolar ventilation, i.e. 
with an optimal A/QV  matching. In paper IV, the „effective‟ shunt model and the 
two-parameter model are compared with a three-parameter model where f2 is varied 
to fit patient data. Study IV investigated the use of the models in describing the 
pulmonary gas exchange of both O2 and CO2. A mathematical model of the acid base 
chemistry of blood [110] was therefore implemented in the models to also describe 
the storage of CO2 in the blood. All model equations as well as the model of the acid-
base chemistry of blood are presented in paper IV. 
 
 
Figure 3: Structure of the physiological models used in the PhD project. 
 
The parameters describing A/QV  mismatch can be transformed into a ΔPO2 value, 
which quantifies the drop in partial pressure of oxygen from the alveoli to the 
capillaries leaving the lungs before the mixing with shunted venous blood. As such a 
ΔPO2 value can be translated directly into the necessary extra pressure of O2 at the 
mouth to alleviate oxygenation problems due to A/QV  mismatch, i.e. if ΔPO2 = 10 
kPa, approximately an extra 10 % oxygen is needed (FiO2 = 0.31).   
2.2 Estimation of model parameters 
The effects of shunt and an alveolar to lung capillary drop in PO2 can be separated by 
performing an experiment where FiO2 is varied in steps and end-tidal O2 and arterial 
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oxygenation are measured at each step after steady state is achieved. Rees et al 
introduced in 2002 an automated method where the steady state was monitored by 
looking at FetO2 enabling a relatively fast experiment, taking approximately 10-15 
minutes when 3-5 FiO2 steps are taken [78]. Arterial oxygenation is estimated using 
pulse oximetry, which has been shown to produce accurate estimates of fs and fA2 
model parameters in a variety of patient groups including intensive care patients 
[103]. 
 
To separate the effects of shunt and an alveolar to lung capillary drop in PO2, the steps 
must be taken so that FetO2-SpO2 points are lying on either side of the characteristic 
shoulder of the FetO2-SpO2 curve. This normally requires variation in SpO2 from 
0.85-1. Shunt affects the FetO2-SpO2 curve in the vertical direction with increases in 
shunt depressing the curve. An alveolar to lung capillary drop in PO2, i.e. as due to 
A/QV  mismatching, causes a horizontal shift in the curve with increase in A/QV  
mismatching and larger PO2 drop causing a shift to the right. Figure 4 shows an 
example of a dataset, where FetO2-SpO2 points lie appropriately, and the two-
parameter model has been fitted to the data.  
 
 
Figure 4: Example of resulting fit (solid line) from estimating model parameters of the two 
parameter gas exchange model, to fit measured FetO2-SpO2 data (+) using equation 1. Patient 
data are from an intensive care patient studied in papers I, II and IV. 
 
Model parameters are estimated using numerical minimization methods finding the 
combination of model parameters resulting in the least weighted squared difference 
between simulated and measured values. Before the PhD project an error function had 
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been developed looking at the error in both the horizontal and vertical directions, as 
stated in equation 1.  
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WRSS is the weighted residual sum of squares, SmO2 is the model predicted SaO2, 
σSpO2 is the standard deviation of SpO2 and σHoriz is the standard deviation in the 
horizontal direction due to measurement uncertainty of FetO2. σHoriz was calculated as 
the difference in SmO2 caused by increasing measured FetO2 by the standard 
deviation of FetO2 measurement (σFetO2).  σSpO2 was set to 0.01 [103] and σFetO2 was 
set to 0.005 [111]. Equation 1 was used to fit the two parameter model in figure 1.  
 
In papers I and II, the measurement data included SaO2 measurements at each level of 
FiO2. SaO2 was therefore used instead of SpO2, to give the best possible model 
description of patient data. In study II this was performed in addition to fitting the 
model to SpO2 data. The standard deviation of SaO2 (σSaO2) was set to 0.005 [112]. 
 
Before study II, the error function was modified to use both SpO2 and SaO2, 
motivated by the fact that a single arterial blood gas measurement is necessary for the 
parameter estimation, so the inclusion of SaO2, which is a more accurate measurement 
of oxygenation than SpO2, as such is free. This also allows the more accurate SaO2 
value to correct some of the error that may occur due to biases sometimes seen 
between SpO2 and SaO2. In addition, the error function was modified to normalize the 
weight of SpO2 measurements in the numerical minimization regardless of the number 
of measurements taken. SpO2 was normalized to four measurements, as having two 
SpO2 points before and after the shoulder of the FetO2-SpO2 curve is sufficient to 
separate shunt and A/QV  effects if the points are well spread. The modified error 
function is stated in equation 2. 
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Equation 2 was used for estimating parameters to calculate INVENT FiO2 suggestions 
in papers II and III. The minima of equation 1 in paper I and equation 2 in papers II 
and III were found using a nested grid search approach with a maximum resolution of 
0.01, i.e. trying all possible combinations of fA2 and fs using steps of 0.01. Figure 5 
shows the same measurement data as Figure 4 but including a SaO2 measurement and 
the model fit using the two-parameter model and equation 2. It can be seen how the 
lower SD of SaO2 means this measurement is prioritized in the fitting procedure.  
 
 
Figure 5: Example of resulting fit from estimating model parameters of the two parameter gas 
exchange model, to fit measured FetO2-SpO2 data (+) using equation 1 (dashed line) and equation 
2 (solid line) utilizing a single SaO2 measurement (o). The other SaO2 measurements taken at 
each FetO2 level are also shown (diamonds) to illustrate the improved agreement with model 
simulation when including a single SaO2 in the model fitting. Patient data are the same as in 
Figure 4. 
 
In paper IV, the aim was to describe pulmonary gas exchange of both O2 and CO2. 
The model was therefore fitted to both the FetO2-SpO2 curve and a single FetCO2-
PaCO2 point. Due to the different scaling of oxygen saturations and PaCO2 as well as 
the different effects of variation of FetO2 and FetCO2, the error function was limited 
to quantify vertical errors. The resulting error function is stated in equation 3. 
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σSpO2 was changed to 0.02 to more closely represent the variation seen in clinical 
studies and the accuracy reported by the manufacturer of the applied pulse oximetry 
device [113,114]. σPaCO2 was set to 0.09 kPa [112]. Equation 3 was in paper IV 
minimized using a nested implementation of Brent‟s method [115]. Implementation of 
a new and faster minimization method was necessary to achieve a practical speed for 
parameter estimation in MatLab (Mathworks, Natick, MA). Figure 6 shows a data 
example from paper IV with the three parameter model fitted to oxygenation and CO2 
data by minimizing equation 3. 
 
 
Figure 6: Example of resulting fit from estimating model parameters of the three parameter gas 
exchange model to O2 and CO2 data using equation 3. Left) Measured FetO2-SpO2 data (+) and 
FetO2-SaO2 point (o) and the resulting model fitted curve (solid line). Right) Measured FetCO2-
PaCO2 point (O), and resulting model fitted simulation of FetCO2-PaCO2 (x).  
 
During the experiments continuous data sampling was performed using RS-232 
interfacing to retrieve: Vt and f from the ventilator (SV300 or ServoI, Marquet, Solna, 
Sweden, papers I-IV) or a volume meter (Elkro Gas, Salerno, Italy, paper I); SpO2 
from a pulse oximetry device (Datex AS-3, Datex-Engström, Helsinki, Finland, paper 
I; SC9000 critical care monitor, Siemens Medical Systems, Munich, Germany, paper 
III; and CO2SMO Plus, Novametrix Medical Systems, Wallingford CT, USA, papers 
I, II and IV); FiO2 and FetO2 from a sidestream oxygen analyzer (Datex AS-3, paper 
I; Oxigraf, Mountain View CA, USA, papers I-IV) and FetCO2 from a sidestream gas 
analyzer (Oxigraf, paper IV). A minimum of one arterial blood sample was drawn 
during each experiment, and analyzed to obtain arterial acid-base and oxygenation 
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status (SaO2, PaO2, pHa, PaCO2, CtHb, FMetHb, and FCOHb) (ABL 525, Radiometer 
Medical A/S, Copenhagen, Denmark, paper I; ABL 625, paper I; ABL 725, papers I, 
II and IV; ABL 800, paper III). The blood gas data were manually entered into the 
computer.  
 
In addition, a number of model variables were assumed to be constant during the 
experiment. Inspired fraction of CO2 was assumed to be 0. Atmospheric pressure was 
assumed to be 101.3 kPa. Saturated water vapour pressure was assumed to be 6.3 kPa 
[77]. Concentration of 2,3-diphosphoglycerate was set to 5 mmol/L as in normal 
arterial blood [110]. Anatomical dead space (VDana) and cardiac output (Q) were also 
assumed constant during the experiments, but were assessed differently between 
studies. In paper I, VDana and Q from the original studies were used [102-104]. In 
papers II and IV, VDana was measured by volumetric capnography (CO2SMO Plus), 
except for two patients in paper IV, where VDana was estimated from the average 
VDana/Vt ratio of the other patients. In the prospective study (paper III) volumetric 
capnography was not available and total apparatus and anatomical dead space was 
assumed to be 0.2 l, as previously used [95]. In studies II, III and IV, Q was either 
measured (PiCCO plus, Pulsion Medical Systems Munich, Germany) or estimated 
from body surface area and an assumed value of cardiac index. Body surface area was 
calculated from patient weight and height using the equation defined by Gehan and 
George [116]. CI was in papers II and III assumed to be 3.0 l/(m
2
min). In paper IV CI 
was assumed to be 3.7 l/(m
2
min), as reported in a large group of intensive care 
patients [117]. 
2.3 Decision support system 
The goal of papers II and III were to evaluate INVENT for decision support of FiO2. 
Therefore a new version of INVENT was implemented for this application. The 
structure of the system is illustrated in Figure 7. Before the system can provide 
suggestions on FiO2, the two-parameter model must be identified using the parameter 
estimation procedure outlined above. This yields patient specific values of the fs and 
fA2 parameter. With parameters estimated and the patient specific variables used 
during parameter estimation input to the system, the physiological model may be used 
to simulate patient responses to changes in FiO2. The model simulates SaO2 and 
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estimates mixed venous O2 saturation (SmvO2) assuming venous pH to be 0.04 less 
than pHa, and mixed venous PCO2 to be 0.8 kPa higher than PaCO2.  
 
The INVENT system uses utility theory in the form of penalty functions to model 
clinical preferences. Each level of FiO2 and predicted oxygenation values are 
associated with a total penalty calculated as the unweighted sum of penalties due to 
local and general ischemia quantified as functions of SaO2 and SmvO2, respectively, 
and due to the risk of oxygen toxicity quantified as a function of FiO2. The 
optimization component of INVENT automatically varies FiO2 and locates the 
optimal level, which is that incurring minimal total penalty. 
 
 
Figure 7: The structure for the INVENT system for decision support on FiO2. Used with 
permission from paper II. 
 
Figure 8 illustrates the user interface of INVENT for FiO2 management. The figure is 
a screenshot taken with data input for a patient from paper III. The left hand side of 
the screen shows the patient specific predicted FiO2-SaO2 curve. On the curve a cross 
encircled by a green circle identifies the system suggested level of FiO2. The system 
allows the clinician to manually vary the FiO2 and see the resulting total penalty. This 
can be done using the button next to FiO2 under the curve in the column “Manual”. 
The currently selected manual FiO2 is marked on the FiO2-SaO2 curve by a vertical 
and horizontal line. In the column “Optimal” under the curve, the system suggested 
level of FiO2 is shown. Under “Manual” and “Optimal” model predicted values of 
SaO2, arterial oxygen concentration (CaO2) and oxygen delivery (DO2) are also 
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shown for the manual and optimal levels of FiO2, respectively. The manual and 
optimal penalties are summarized in the bar plot next to the FiO2-SaO2 curve. The 
manual FiO2 in the screenshot corresponds to the FiO2 selected by the attending 
clinician in paper III. 
 
The right hand side shows the three penalty functions in the system, and a summary of 
the penalties associated with the manually selected FiO2 level.  
 
 
Figure 8: A screenshot of the INVENT system taken during study III. Used with permission from 
paper III. 
 
2.4 ICARE system and database 
The INVENT system and the parameter estimation procedure are implemented in a 
system, ICARE, developed at MMDS, Aalborg University [118]. The system includes 
software for communication with devices using RS-232 interfacing. It incorporates a 
MySQL database for storing all data from devices as well as model simulation data 
and INVENT suggestions. The system also includes autonomous agents responding to 
changes in specific data and calculating new values of derived variables. E.g. when a 
new value of height or weight is available an autonomous agent calculates a new 
value of body surface area. All added data are stored with an ID referring to the 
patient they describe. All stored data are also associated with a timestamp, a rank, and 
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their origin. The rank can be measured, calculated, estimated or default illustrating the 
quality of the data. Origin allows the user to see the device or software system, e.g. 
INVENT, which input the data. 
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3. Summary of Papers 
3.1 Paper I 
Aim 
To evaluate the relevance of variation in the PaO2/FiO2 ratio with FiO2. PaO2/FiO2 is 
the current dominating hypoxemia index used in intensive care and clinical trials. The 
study was also performed to evaluate the ability of a shunt only model to describe this 
variation in comparison with a two parameter model describing shunt and 
ventilation/perfusion mismatch. 
Methods 
The study was a retrospective evaluation. Several patient groups were included to 
allow the analysis to be performed simulating as many different forms of lung 
disorders and severities of gas exchange problems as possible. Experimental data 
were included from normal subjects [103], postoperative patients following 
gynaecological laparotomy [102,103] and cardiac surgery [103,104], patients 
suffering from cardiac incompensation [103], intensive care patients from a 
previously published study [103] and previously unpublished experimental data from 
a further 8 intensive care patients (see paper II, section 3.2) totaling 93 patients 
studied. A total of 36 patients were mechanically ventilated intensive care patients 
whereas 57 were spontaneously breathing. Some of the patients were studied on more 
than one occasion, e.g. after changes in PEEP, yielding a total of 134 patient cases. 18 
patient cases (spontaneous breathing) were excluded as measurement data only 
included arterial blood gas measurements at two levels of FiO2. 
First the two-parameter model was used to show the theoretical variation in 
PaO2/FiO2 upon changing FiO2 under different levels of shunt and A/QV  mismatch. 
The variation was analysed in a clinically relevant range, which was defined as the 
range of FiO2 corresponding to simulated SaO2 values in the range 92-98%. The 
variation was then analysed in 116 patient cases, using both the one parameter 
„effective‟ shunt model and the twoparameter model to fit patient data and simulate 
variation in PaO2/FiO2 ratio. The value of the PaO2/FiO2 ratio as hypoxemia index 
was then evaluated by classifying each patient as being normal (PaO2/FiO2 > 47 kPa), 
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having mild hypoxemia (40 kPa ≤ PaO2/FiO2 < 47 kPa), ALI (27 kPa ≤ PaO2/FiO2 < 
40 kPa) or ARDS (PaO2/FiO2 < 27 kPa) [1]. This was done at the minimum and 
maximum FiO2 of the patient specific clinically relevant ranges, and the number of 
patients changing classification from low to high FiO2 were quantified.  
Data are reported as means ± SD appearing normally distributed on graphic 
evaluation of Q-Q plots [119]. F-tests were used to compare goodness of fit between 
the shunt-only model and the two parameter model, taking into account the degrees of 
freedom lost with additional complexity. A confusion matrix [120] was used to 
illustrate the number of patients classified as normal, with mild hypoxemia, ALI or 
ARDS upon changing FiO2. A cut-off value of 0.05 was used for signifying statistical 
significant differences in the F-test. 
Results 
Figure 9 and Figure 10 illustrate the theoretical variation in SaO2 and PaO2/FiO2 ratio 
upon changing FiO2 under different levels of shunt and A/QV  mismatch, 
respectively. Figure 11 illustrates measured and model simulated variation in SaO2 
and PaO2/FiO2 in six patients representing typical examples from the studied patient 
groups. The two parameter model was shown to give a statistically better fit to data 
than the „effective‟ shunt model (P < 0.005).  
 
 
Figure 9: Simulated variation in SaO2 (A) and PaO2/FiO2 ratio (B) upon changing FiO2 under 
varying levels of shunt (fs). Thick solid lines indicate the portion of the curves within the 
clinically relevant range of FiO2. a and b in subplot B indicate a variation in FiO2 from 0.19 to 
0.57 for fs=20%. Simulations were performed using ΔPO2 = 0 kPa (fA2=0.9), VO2 = 0.26 l/min, 
alveolar minute volume =  5.25 l. Used with permission from paper I. 
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Figure 10: Simulated variation in SaO2 (A) and PaO2/FiO2 ratio (B) upon changing FiO2 under 
varying levels of A/QV  mismatch (ΔPO2). Thick solid lines indicate the portion of the curves 
within the clinically relevant range of FiO2. a and b in subplot B indicate a variation in FiO2 from 
0.26 to 0.35 for fs=20%. Simulations were performed using fs = 5 %, VO2 = 0.26 l/min, alveolar 
minute volume =  5.25 l. Used with permission from paper I. 
 
Disease classification changed upon varying FiO2 within the clinically relevant range 
in 38 of the 116 patient cases (~30%) according to the two-parameter model. The 
number of patient cases classified as ALI or ARDS according to the two-parameter 
model changed from 23 to 31 (~35% increase) and from 18 to 24 (~33% increase), 
respectively. 
 
 
Figure 11: Model simulations and measured patient data, for six patients representing typical 
cases. i: Measured and simulated variation in SaO2 with changes in FiO2. ii: Measured and 
simulated variation in PaO2/FiO2 with changes in FiO2. (a): Normal subject [103], (b): cardiac 
incompensation subject [103], (c): Gynaecological laparotomy patient [102,103], (d): cardiac 
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surgery patient [104], (e): intensive care patient [103], (f): patient from the previously 
unpublished study in intensive care patients. Solid lines and dashed lines indicate models 
simulations with the two-parameter model, and the ‘effective’ shunt model, respectively, thick 
part of curves correspond to the clinically relevant range of FiO2. Model parameters and root 
mean square (RMS) error are specified for each model. + represent measured patient data. Used 
with permission from paper I. 
Conclusions 
The PaO2/FiO2 ratio is dependent on both the levels of FiO2 and SaO2. Within the 
ranges investigated (SaO2 = 92-98 %) almost a third of patients change disease 
classification. Therefore the scientific and clinical utility of the PaO2/FiO2 ratio 
appears questionable. If used, then at least the FiO2 level at which the ratio was 
measured should be reported. The results indicate that the one-parameter „effective‟ 
shunt model is not capable of describing this variation correctly, but that the two 
parameter model is.   
 
 41 
3.2 Paper II 
Aim 
To retrospectively evaluate INVENT for the ability to provide appropriate suggestions 
of FiO2 in intensive care patients. 
Methods 
Patient data were used from a study in intensive care patients. Data from 8 of the 
patients had been used in paper I, the remaining were previously unpublished. The 
study had been approved by the ethical committee of North Jutland and Viborg 
Counties and the ethical committee of Copenhagen. Informed consent was obtained 
from relatives or nearest guardian. The study inclusion criteria were eighteen years of 
age or more and requirement of mechanical ventilation with levels of FiO2 higher than 
0.4. Exclusion criterion was a highly dynamic patient condition potentially affecting 
measured respiratory parameters during the experiment. This was secured by 
excluding patients with base excess less than -6 mmol/L and serum lactate level 
greater than 4 mmol/L. Measurement data were used from 18 intensive care patients 
with ALI. Two of the 18 patients were excluded as malfunction of the data collection 
software had prevented successful experiments. The patients had been studied at 
Rigshospitalet (Copenhagen, Denmark), as part of a protocol investigating the effects 
of changes in PEEP. Therefore in several of the patients measurement data were 
available at two PEEP settings, and a total of 27 patient cases were available, and used 
in the retrospective evaluation. Median age and weight of the patients were 64.5 years 
(range 27-85 years) and 80 kg (range 70-140 kg), respectively. 
The two parameter model was fitted to patient data (SpO2 and a single SaO2), and 
INVENT was used to calculate the suggestion of FiO2 (FiO2
sugg
). This was compared 
to the FiO2 level and corresponding SaO2 values used in clinical practice (FiO2
clin
, 
SaO2
clin
). An additional model fit was also performed in each patient case fitting the 
model to measured SaO2 values at each FiO2 level, representing the best possible 
model description of the patient. This model fit was used to calculate the „true‟ 
resulting SaO2 (SaO2
true
) from using INVENT advice. As such, this allowed an 
estimate of the effect of using SpO2 combined with a single SaO2 value in model 
fitting to predict patient response to changes in FiO2.   
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Data are reported as median (range) as they did not appear normally distributed on 
graphic evaluation of Q-Q plots. Wilcoxon matched pairs tests were used to compare 
INVENT FiO2 and SaO2 values with clinician FiO2 and SaO2. Bland-Altman plots 
[121] were used to evaluate the agreement between SpO2 and SaO2. A cut-off value of 
0.05 was used for signifying statistical significant difference. 
 
 
Figure 12: Scatter plot of measured FiO2
clin
 versus measured SaO2
clin
 (o), and FiO2
´sugg
 versus 
model simulated resulting SaO2
sugg
 (x). Used with permission from paper II. 
 
Results 
Figure 12 shows a scatter plot of FiO2 levels selected in clinical practice plotted 
against corresponding measured SaO2 values and INVENT suggested FiO2 levels 
plotted against model simulated SaO2 values. The same is shown in Figure 13 but 
with model simulated SaO2 replaced by the simulated „true‟ resulting SaO2 values. 
Table 1 reports the median and ranges of measured and simulated FiO2 levels and 
SaO2 values. 
 
FiO2
clin
 and FiO2
sugg
 as well as SaO2
clin
 and SaO2
sugg
 were significantly different 
(P<0.01). SaO2
sugg
 and SaO2
true
 were also significantly different (P<0.05). The scatter 
plots and ranges of the values show that ranges of INVENT FiO2 and SaO2 values are 
narrower than those used in clinical practice. INVENT maintained FiO2 below 60 % 
in all cases but one where the system used 64 %, whereas FiO2 levels higher than 70 
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% were used in several patients in clinical practice. All measured and simulated SaO2 
values were above 89 %. 
 
 
Figure 13: Scatter plot of FiO2
clin
 versus SaO2
clin
 (o), and FiO2
sugg
 versus model simulated ‘true’ 
resulting SaO2
true
 (x). Used with permission from paper II. 
 
Table 1. Median and range of clinical and INVENT values. Adapted from paper II with 
permission. 
 Median Min Max 
FiO2
clin
 (%) 53.3 38.6 82.6 
FiO2
sugg
 (%) 44 33.0 63.5 
SaO2
clin
 (%) 96.8 90.9 99.1 
SaO2
sugg
 (%) 94.2 91.4 96.3 
SaO2
true
 (%) 94.9 89.2 97.1 
Conclusions 
INVENT suggests appropriate levels of FiO2 and SaO2, acting to minimize risk of 
oxygen toxicity whilst maintaining adequate oxygenation. Although using pulse 
oximetry to estimate arterial oxygen saturation introduces noise in model predictions, 
the resulting SaO2 values remain within safe ranges in all patients. 
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3.3 Paper III 
Aim 
To prospectively evaluate the ability of INVENT to provide appropriate suggestions 
of FiO2 in intensive care patients.  
Methods 
The study was performed from November 2007 to March 2009 in a four-bed intensive 
care unit at Aalborg Hospital (Aalborg, Denmark). Inclusion criteria were broad and 
there were few exclusion criteria in order to evaluate INVENT in a patient population 
covering patients normally residing in an ICU. Inclusion criteria were eighteen years 
of age or more and requirement of mechanical ventilation. Patients were excluded if 
they required an FiO2 level higher than 0.8. The other exclusion criteria were clinical 
suspicion of lung emboli, critical hemodynamic status, and pregnancy, all being cases 
where the physiological model has not been validated yet. A total of 15 patients were 
included, two of which were excluded before data analysis. In addition, a single 
experiment was excluded, as the patient was turned during the experiment affecting 
the gas exchange status of the patient. Up to four experiments were performed in each 
patient totaling 45 patient cases available for analysis. 
Patients were studied over two consecutive days performing two experiments per day. 
In each experiment both INVENT and the attending clinician managed FiO2 shifting 
sequence between experiments. Between INVENT and clinician FiO2 management, 
FiO2 was reset to baseline level and 5 minutes was allowed for equilibration [77]. An 
arterial blood gas measurement was taken at baseline and 5 minutes after each change 
in FiO2.   
Data are reported as means ± SD or as median (interquartile range [range]) if not 
appearing normally distributed on graphic evaluation of Q-Q plots. A box and whisker 
plot was used to compare overall FiO2 changes from baseline level by attending 
clinicians and INVENT [119]. Linear regression was used to analyse the relationship 
between selected FiO2 levels and resulting measured SaO2 values for baseline, 
attending clinicians and INVENT. Pearson correlation coefficients were calculated to 
quantify the strength of these linear relationships. 
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Results 
Median time between two consecutive experiments was 74 (60-123 [50-302]) 
minutes. Attending clinicians varied FiO2 in 22 out of the 45 experiments (49 %), 
whereas INVENT varied FiO2 in 43 experiments (96 %) showing a more frequent 
response to changes in patient state by INVENT. Both attending clinician and the 
INVENT selected to change FiO2 in 20 out of the 45 experiments (44 %). These 
changes were all in the same direction from baseline level. There were no experiments 
where attending clinicians and INVENT selected opposite directions of changes in 
FiO2. 
 
INVENT was more prone to change FiO2 from baseline level and to make larger 
changes compared to attending clinicians, as illustrated in the box and whisker plot in 
Figure 14.  
 
 
Figure 14: Box and whisker plot of changes in FiO2 from baseline level by attending clinicians 
(Clin) and INVENT (DSS). Used with permission from paper III. 
 
Figure 15 illustrates scatter plots of baseline, clinician and INVENT selected levels of 
FiO2 versus measured values of SaO2, allowing an evaluation of the reasonableness 
eness of INVENT advice compared to clinicians on a population basis. Both the 
ranges of selected FiO2 and resulting SaO2 were narrower for INVENT in comparison 
with baseline and clinician ranges. Linear regression lines are also shown, illustrating 
the compromise of balancing FiO2 and SaO2. The resulting linear models and Pearson 
correlation coefficients with P-values were: for baseline: SaO2 = -0.036 FiO2 + 0.976 
(-0.159, P = 0.296); for attending clinicians: SaO2 = -0.026 FiO2 + 0.968 (-0.142, P = 
 46 
0.351); and for INVENT: SaO2 = -0.111 FiO2 + 1.001 ( -0.579, P < 0.001), showing 
that only the correlation for INVENT was statistically significant. 
 
 
 
 
 
 
 
 
 
 
Figure 15: Scatter plots of FiO2 versus measured SaO2 in each patient case: A) at baseline, B) set 
by attending clinicians, and C) set following INVENT suggestions. Solid lines illustrate linear 
regressions for the relationship between FiO2 and SaO2. Used with permission from paper III. 
 
 
Interesting differences emerged when looking at selected levels of FiO2 and measured 
SaO2 on an individual patient basis during the four experiments. Figure 16 illustrates 
clinician (Figure 16A, B) and INVENT (Figure 16C, D) FiO2 and SaO2 in 6 of the 
patients. For example, in one patient, INVENT was more capable of preventing a 
large drop in SaO2 due to change in patient status between experiments (patient 
illustrated by squares), in another case, INVENT seemed too prone to increase FiO2 
from a low level when it was not necessary (patient illustrated by dots). 
 
As an interesting technical note aside, Figure 17 illustrates a Bland-Altman plot of the 
agreement between model predicted values of SaO2 and the resulting measured 
values. The model predicted on average somewhat lower SaO2 with a mean difference 
of -0.005 ± 0.012. No systematic bias can be identified from the plot. This plot was 
not included in paper III. 
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Figure 16: Selected levels of FiO2 and SaO2 in the four experiments in 6 of the patients. A) and B) 
clinician FiO2 and SaO2, respectively. C) and D) INVENT FiO2 and SaO2, respectively. Used with 
permission from paper III. 
 
 
 
Figure 17: Bland-Altman plot of agreement between model predictions of SaO2 (SaO2,pred) and 
measured resulting SaO2 (SaO2,res) from using INVENT FiO2 suggestions. Values on the x-axis 
are the average SaO2 of each set. Solid line is the average difference across all patient cases and 
dotted lines are the limits of agreement (average difference ± 2SD). Patient cases from the same 
patient are shown with identical point markers. Used with permission from paper III. 
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Conclusions 
Results indicate that the INVENT system is safe to use for suggesting FiO2 levels in 
intensive care patients. The physiological model accurately predicts SaO2, and all 
FiO2 levels suggested by INVENT resulted in appropriate values of SaO2. Both 
clinicians and INVENT often changed FiO2 when evaluating patients suggesting that 
frequent reevaluation of the patients is valuable. INVENT may help to understand 
difficult patients, and in easily managed patients the system may be used to free the 
focus of clinicians to concentrate on more challenging therapy. 
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3.4 Paper IV 
Aim 
To perform a systematic comparison of different minimal models to find the 
necessary degree of modeling complexity to describe the pulmonary gas exchange of 
both O2 and CO2 and provide an adequate description of gas exchange abnormality in 
intensive care patients. 
Methods 
The study was carried out as a retrospective study. The data used in paper II were 
selected, as these patients had severe disorders in pulmonary gas exchange. After 
publication of paper II the data from two additional patients were made available 
totaling 18 patients for the analysis. As several patients had been studied at two levels 
of PEEP a total of 30 patient cases were available.  
Three different models were compared: an one parameter „effective‟ shunt model 
(Model I); a two parameter model as used in papers I, II, and III describing shunt and 
A/QV  mismatch, with perfusion locked between two ventilated compartments, and 
fraction of ventilation varied to fit patient data (model II); and a three parameter 
model, similar to model II but where also the fraction of perfusion going to the two 
ventilated compartments is varied to fit patient data. The three models were compared 
quantitatively for their ability to fit patient data taking into account the degrees of 
freedom lost with increasing complexity, and qualitatively for their ability to describe 
the gas exchange abnormality of the individual patients.  
Data are reported as means ± SD appearing normally distributed on graphic 
evaluation of Q-Q plots. F-tests were used to compare goodness of fit between 
models, taking into account the degrees of freedom lost with more complex models. χ
2
 
tests were also used to evaluate the goodness of fit of the models on a patient case 
basis. A Bland-Altman plot was used to evaluate the agreement between SpO2 and 
SaO2. A cut-off value of 0.05 was used for signifying statistical significant differences 
in F-tests. In the χ
2
 tests P>0.1 was used as cut-off for signifying an adequate fit to 
measurement data. 
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Results 
Chi-squared tests of quality of fit to individual patient cases indicated adequate fit to 
measured data (P>0.1) in 1 patient case for model I (3% of cases), 19 (63%) patient 
cses for model II and in 24 (80%) patient cases for model III. Pairwise F-test 
comparisons showed model II to give a significantly better fit to measured data than 
model I (P<0.001), and indicate model III to give better fit than model II (P<0.1), 
however with low statistical significance. 
Figure 18 shows an example of model fits to measured O2 and CO2 data in a patient 
case where only model III provides an adequate fit to both O2 and CO2. Both models 
II and III fit the CO2 data, but model II can not simulate sufficient right shift in the 
FetO2-SpO2 curve, i.e. describe a sufficient alveolar to lung capillary drop in PO2. 
Of the 6 patient cases where chi-squared tests showed that model III produced an 
inadequate fit to data, 1 patient could be described by model I, i.e. shunt was 
sufficient to describe the data. In another case, model II was sufficiently complex to 
describe measured data. In the last 4 patient cases, there was a significant bias 
between SpO2 and SaO2. However, in these cases fitting model III to SaO2 showed 
small differences in resulting described degree of lung disorder according to the 
difference between alveolar and arterial partial pressures of O2 and CO2.  
 
Figure 18: Fit of the three models to measured patient data, in a patient case, where only model 
III provides a good fit to both O2 and CO2 data. Left) Model fitted simulations of oxygenation for 
model I (dashed line), model II (dotted line) and model III (solid line), and measured FetO2-SpO2 
(+) and FetO2-SaO2 (o) points. Right) Model fitted simulations of FetCO2-PaCO2 for model I 
(diamond), model II (triangle) and model III (x) and measured FetCO2-PaCO2 (o) point. 
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Figure 19 shows model fitted ventilations and perfusions of the two ventilated 
compartments versus A/QV  of the respective compartments for models II and III. For 
each patient case there are two points in each sub plot: one for the low A/QV  
compartment and one for the high A/QV  compartment. The ranges of A/QV  ratios 
that model III can describe are broader than those of model II. This is in particular 
obvious in the middle ranges of A/QV  ratios when comparing ranges of perfusion (A 
and C), and in the lowest range of A/QV  ratios when comparing ventilation (B and 
D). 
 
 
Figure 19: Model fitted perfusion and ventilation of ventilated compartments 1 (upward 
triangles) and 2 (downward triangles) versus ventilation/perfusion ratios in the respective 
compartments. A: perfusion to ventilated compartments of model II. B: ventilation to ventilated 
compartments of model II. C: perfusion to ventilated compartments of model III. D: ventilation 
to ventilated compartments of model III. Filled triangles indicate patient cases where Chi-
squared tests of quality of fit resulted in p>0.1 for model III and p<0.1 for model II, or where the 
resulting p for model III was at least 0.2 larger than that for model II.  
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Conclusions 
The results show that the one parameter model is not able to describe pulmonary gas 
exchange of O2 and CO2. The two parameter model is sufficiently complex to 
describe gas exchange of one of the two gases, but is not able describe gas exchange 
of both gases in all patients. The three parameter model is able to provide adequate 
fits to measured O2 and CO2 data, and is robust in the cases where SpO2 provide a 
poor estimate of SaO2. The three parameter model is able to provide a more varied 
description of A/QV  ratios in different patients. As such this minimal model 
represents a good compromise between complexity and feasibility, and may be used 
in clinical practice to describe lung status in patients with severe lung disorders. 
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4. Discussion 
Ventilator management can be considered a process of finding the appropriate 
compromise between conflicting goals, it is important to secure gas exchange, but at 
the same time excessive levels of pressures, volumes and FiO2 should be avoided to 
prevent VILI. This is a complex task requiring a good understanding of the 
pathophysiology of the individual patient. Although numerous measurements are 
available in the ICU to describe the gas exchange status of the lungs, currently 
available measurements are over-simplified and vary with changes in therapy not 
affecting lung status. Model-based DSSs constitute a potential solution by offering a 
deeper understanding of the patient‟s lung status and by integrating measurement data 
and suggesting optimal therapy.  
The overall aim of this PhD project was to evaluate the use of minimal models of gas 
exchange in decision support of ventilator management. Four questions were 
addressed during the project, see section 1.5. In the following the answers to these 
four questions are discussed based on the results presented in the four papers. In the 
following sections the INVENT system as well as results of the PhD project are 
discussed in relation to: rule-based DSSs and other model-based DSSs. In addition, 
this chapter will discuss the necessary future work to allow INVENT to provide 
decision support of FiO2, Vt and f in intensive care patients, and what is necessary to 
also provide suggestions on PEEP. As a final discussion on decision support, this 
chapter will discuss the necessary steps to be taken to achieve a successful integration 
of INVENT in clinical practice. This chapter will also examine the limitations of the 
mathematical models and parameter estimation methods used in all the studies 
presented in this thesis. Finally other relevant clinical perspectives related to the 
project are discussed.    
4.1 The major findings of this thesis 
Paper I shows that the currently dominating oxygenation index, the PaO2/FiO2 ratio 
varies significantly with changes in FiO2. This has been shown both theoretically, 
according to a two parameter gas exchange model describing shunt and A/QV  
mismatch, but also in various patient groups including intensive care patients. The 
clinical and scientific value of the index therefore appears doubtful. A shunt only 
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model can not describe this variation accurately, but the two parameter model can. 
The results presented in paper I illustrate that a two parameter gas exchange model is 
necessary  to accurately predict changes in oxygenation with FiO2, and is therefore the 
necessary complexity for decision support of FiO2 in the ICU. 
 
A two parameter model describing shunt and A/QV  mismatch is an integrated part of 
the INVENT system originally presented by Rees et al. [73]. As a first step towards 
clinical integration INVENT was modified in this PhD to provide decision support of 
FiO2. This version of INVENT is based on the two parameter gas exchange model 
alone to predict patient response to changes in FiO2. In addition, the parameter 
estimation procedure was modified to include arterial oxygen saturation measured 
from an arterial blood sample. Paper II describes the retrospective evaluation of 
INVENT for decision support of FiO2 in intensive care patients. The results indicate 
that INVENT suggests appropriate levels of FiO2 and SaO2. However, the study was 
retrospective and resulting oxygenations were predicted by model simulations, 
therefore the study is limited to indicate that INVENT is safe to use in an ICU. 
 
Paper III presents the prospective evaluation of INVENT for providing decision 
support of FiO2 in 13 intensive care patients in up to four experiments over two 
consecutive days. Although the number of patients was limited, the results indicate 
that INVENT provides safe and appropriate suggestions of FiO2 in intensive care 
patients with varying severities of respiratory failure. The scatter plots illustrating 
INVENT FiO2 versus resulting SaO2 (Figure 15C) show that INVENT standardizes 
the compromise of achieving sufficient oxygenation versus avoiding the adverse 
effects of hyperoxia, these compromises being patient specific as INVENT 
suggestions are based on model parameters estimated to describe the individual 
patient. When higher FiO2 is required, INVENT accepts lower SaO2. Both in the 
retrospective and the prospective study, it appears that INVENT managed this balance 
as well as or better than attending clinicians. 
 
INVENT was originally designed to provide decision support of FiO2, Vt and f [73]. 
To provide appropriate suggestions of Vt and f, it is necessary to also model the 
pulmonary gas exchange of CO2 as changes in alveolar ventilation caused by changes 
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in Vt and f modify gas exchange of CO2 and thereby affect the acid-base status of the 
blood. Paper IV describes a systematic evaluation of what modeling complexity is 
necessary to obtain an accurate minimal model representation of pulmonary gas 
exchange of both O2 and CO2. The results presented in paper IV show that a three 
parameter model describing shunt and A/QV  mismatch can accurately describe O2 
and CO2 gas exchange in intensive care patients. The two parameter model describing 
shunt and A/QV  mismatch was sufficient in the majority of patient cases but failed in 
some. In comparison, the three parameter model can describe broader ranges in 
A/QV  ratios and is able to describe perfusion to a model compartment with very low 
A/QV  ratios, close to 0.1. This is an interesting quality as perfusion of lung regions 
with very low A/QV  ratios has been described in ARDS patients in studies using the 
MIGET technique [94,95]. The two parameter model could not provide such a 
physiological description. 
4.2 Model-based or rule-based decision support systems? 
The successful prospective evaluation of INVENT for suggestions of FiO2 is an 
important indication of the clinical usability of a model-based DSS. However, in 
comparison numerous clinical trials have been performed with rule-based systems 
including large multicenter studies and often in complex problems involving several 
ventilator settings. Rule-based systems have also been successfully implemented in 
commercial ventilators. Development of a model-based decision support system is a 
complex and time-consuming task involving mathematical description of a complex 
physiological system, quantification of clinical preferences and development of 
methods for estimating model parameters from clinical data. Indeed, given the current 
status of rule-based systems compared to model-based systems one may ask, is it still 
worth it? 
 
There is no doubt that under certain conditions use of a rule-based system may result 
in improvement in patient care [e.g. 47,53] and in general standardize care, which is a 
quality in itself [40]. Multicenter studies have also shown that this can be achieved 
with the same system successfully across several institutions [47,53]. It may also be 
argued that compared to a model-based DSS, a rule-based DSS in the simplest form is 
of relatively low cost to build, for example by implementing a computerized version 
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of a clinical guideline. However, rule-based systems remain blackbox systems, which 
do not provide the clinician with a deeper understanding of the patient nor the 
provided advice. Implementation of intelligent graphic user interfaces have been 
suggested to address this problem [67], however, graphic interfaces do not help 
clinicians in understanding the provided advice, and would likely be more valuable 
with an underlying physiological interpretation of the patient as in a model-based 
DSS. 
 
When estimated, the model parameters for the two parameter gas exchange model 
used in INVENT provide a physiological interpretation of the individual patient. The 
fs parameter quantifies the degree of intrapulmonary shunt, and the fA2 parameter 
describes the degree of A/QV  mismatching. This is directly related to the response of 
the individual patient to changes in FiO2, as increases in intrapulmonary shunt causes 
a vertical depression of the FiO2-SaO2 curve, i.e. changes in FiO2 have less effect on 
SaO2. An increase in A/QV  mismatching (low fA2) causes a horizontal right shift in 
the FiO2-SaO2 curve. This can be translated to a ΔPO2 value, which describes the 
extra amount of oxygen necessary at the mouth to counter the oxygenation problem 
due to A/QV  mismatch.   
 
The requirement of a parameter estimation procedure may be regarded as a limitation 
of model-based DSS compared to rule-based DSSs. The parameter estimation 
procedure used to identify the two parameter gas exchange model in INVENT 
requires variation in FiO2 and measurement of oxygenation using pulse oximetry, a 
single arterial blood gas analysis and measurement of oxygen fraction in the expired 
air. Variation of FiO2 is a common procedure in an ICU and only measurement of 
expired gas fractions can be considered not a part of routine clinical data. However, 
these measurements can be obtained from medical equipment, and as shown in paper 
I, they are necessary for an accurate description of pulmonary gas exchange. In 
addition, the parameter estimation procedure could safely be performed by a nurse, 
and Bayesian methods have been developed for supporting the selection of FiO2 steps 
and potentially making the procedure computer controlled [122]. Of course, clinicians 
or nurses could vary FiO2 without a computer system to better understand patient 
responses to changes in FiO2. This would, however, be time-demanding requiring 
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resources not normally available in clinical practice. Without tools as those presented 
by Rees et al. [78] to monitor equilibration after changes in FiO2, it is necessary to 
allow 5 minutes for equilibration [77] prolonging the process compared to using the 
DSS. In addition, although varying FiO2 without a DSS would give clinicians a better 
understanding of the gas exchange status of the patient, it would not help to 
standardize clinical preferences when managing FiO2. 
 
Another possible advantage of model-based DSS is removal of the need for a trial and 
error approach to locating the appropriate ventilator settings [68]. However, this is 
under the assumption that the physiological models accurately predict patient 
response to changes in therapy. The good agreement between model simulated SaO2 
from fit to pulse oximetry with model simulated SaO2 from fit to SaO2 reported in 
paper II (Figure 12 and Figure 13) indicate that the two parameter gas exchange 
model accurately predicts patient response to changes in FiO2. This was confirmed in 
the prospective study as shown in Figure 17. 
 
INVENT uses utility theory in the form of penalty functions to decide therapy. The 
penalty functions in INVENT quantify clinical preferences, e.g. preventing ischemia. 
The suggestions provided by INVENT are associated with penalties calculated using 
the relevant penalty functions. As such, the compromises between conflicting goals 
made by INVENT are made explicit to the clinician allowing an understanding of the 
provided advice. 
4.3 Current status of model-based decision support of 
mechanical ventilation 
Several model based DSS or hybrid systems combining models with rules have been 
developed to assist clinicians in managing mechanical ventilation as outlined in the 
introduction. In the following, the various qualities of the systems are discussed 
including how the results obtained in the PhD project contributes to the field of 
model-based decision support of mechanical ventilation. The different systems are not 
directly comparable for their ability to provide appropriate suggestions of changes in 
therapy as they provide advice for different ventilator settings, use different 
measurements for evaluation or have been tested under different conditions. In the 
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following discussion the systems are instead compared with regards to the potential 
clinical benefits they may provide and their clinical feasibility. The VentPlan system 
[71] was very similar to INVENT in terms of modeling and use of decision theory. 
However, the development of VentPlan has stopped and it will not be discussed 
further, but it should be noted that several of the qualities of INVENT discussed in the 
following were also qualities of the VentPlan system. 
 
To the best of my knowledge, the prospective evaluation of INVENT presented in 
paper III is the first prospective evaluation of a model-based medical decision support 
system for ventilator management since the studies with the OPTPROG system by 
Rudowski et al. in the early nineties [69,70]. OPTPROG was prospectively evaluated 
for suggestions on f, Vt and PEEP, which represent a more complex problem than 
management of FiO2. However, OPTPROG had several issues which likely would 
prevent routine clinical use. OPTPROG was based on linear models with model 
parameters having no physiological interpretation. As such the users would have little 
extra to gain from using this system compared to a rule-based system, except the 
potential of preventing trial and error when selecting therapy. Despite the simple 
model, the parameter estimation procedure took approximately one hour and required 
four arterial blood gas measurements [69,70], a frequency of arterial blood sampling 
in excess of that normally used in clinical practice. Rudowski et al. argued that when 
enough patient data was accumulated, statistical analysis could be used to acquire a 
priori knowledge of model parameters potentially simplifying or obviating the 
parameter estimation procedure [69]. However, the heterogeneity of ALI/ARDS 
patients reported in clinical studies strongly contradicts this [e.g. 36,37]. 
 
The SIVA system [72] is based on a two parameter physiological model of gas 
exchange to simulate patient response to changes in FiO2, and empirical models to 
simulate patient response to changes in respiratory frequency and inspiratory pressure 
[72]. The two parameters of the gas exchange model have a physiological 
interpretation [75], however, the authors stated that estimation of model parameters 
requires a pulmonary artery catheter and that there were convergence problems. As 
such, the authors suggested that for prospective use, shunt should be estimated using a 
fuzzy inference system [62] and physiological dead space had to be estimated by the 
clinician [72]. The parameter estimation is therefore limited to requiring an arterial 
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blood gas sample at a single level of FiO2. The system has at present only been 
evaluated using model simulations, preventing any conclusions on the accuracy of 
model predictions.  
 
The FLEX system uses several simple models to describe patient response to changes 
in FiO2, PEEP, f and I:E-ratio [74]. All the models implemented in FLEX are either 
very simple without any model parameters or empirical having parameters without a 
physiological interpretation. These empirical model parameters are not tuned to 
describe the individual patient. The simple nature of the models used in FLEX allows 
the system to be used from measurements readily available at the bedside in the ICU, 
however, this also prevents FLEX from providing the clinician with a deeper 
physiological understanding of the patient.  
 
FLEX incorporates scalability such that if certain measurements are not available the 
system uses a different, i.e. simpler, approach to calculate suggestions. This can be a 
valuable quality of the system, especially when used outside the ICU where 
measurements of lung status are sparse. The different methods used in this PhD 
project (see section 2.2) illustrate that the parameter estimation procedure used for the 
gas exchange model in INVENT is to some extent scalable. In addition it has been 
shown that in patients with cardiac incompensation the parameters can be estimated 
without an arterial blood gas measurement using default values [123]. However, it 
would still be necessary to measure variation in oxygenation with varying FiO2 to 
separate the effects of shunt and A/QV  mismatch. 
 
Both SIVA and FLEX are hybrid systems using models in combination with rules to 
calculate suggestions on changes in therapy. As such these systems, like rule-based 
systems, do not make it obvious to the clinician what compromises have been made 
by the system. 
4.4 Future work 
The version of INVENT originally presented by Rees et al. in 2006 was intended for 
decision support of not only FiO2 but also of Vt and f [73]. In the following, the 
relevance of providing decision support on these settings is discussed as well as the 
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future work necessary to enable prospective evaluation of INVENT for suggesting 
FiO2, Vt and f in an ICU. Thereafter it is discussed what future work may allow 
INVENT to provide suggestions on PEEP, for which the appropriate levels remains 
elusive. Finally this section will address the necessary work required to facilitate 
future clinical integration of INVENT. 
Advice on FiO2, Vt, and f 
A recent epidemiological study by Esteban et al. showed that tidal volumes in general 
have been decreased in ARDS patients in clinical practice, but also that this has not 
reduced mortality more than 5 percent since 1998 [124] and ICU and hospital 
mortality in ARDS patients remain above 50% and 60%, respectively [124]. Several 
reasons may have contributed to this apparently high mortality in comparison with 
those of the multicenter clinical trials reporting mortalities below 30% [e.g. 28,30]: 
the studied populations may have been more heterogeneous; the design of the 
retrospective study by Esteban et al.; change in composition of patients presenting in 
the ICU; or perhaps the difficulty for clinicians to use the guidelines in clinical 
practice for the benefit of individual patients? Use of a DSS could potentially help to 
standardize care according to the individual patient.  
 
INVENT has been shown retrospectively to provide appropriate suggestions of FiO2, 
Vt and f in cardiac surgery patients mechanically ventilated in an ICU [125]. In these 
patients the two parameter gas exchange model was successfully used to describe the 
pulmonary gas exchange of O2 and CO2. However, the results presented in paper IV 
illustrate that a three parameter model is necessary to describe both O2 and CO2 gas 
exchange in intensive care patients. As such, this model must be implemented in 
INVENT before an eventual retrospective or prospective evaluation in intensive care 
patients. This will require a measurement of end-tidal fraction of CO2 in addition to 
the measurements used for estimating model parameters to describe O2 gas exchange. 
Paper IV was limited to compare minimal models in intensive care patients 
representing some of the most complex respiratory failure patients with regards to gas 
exchange. The two parameter model may be sufficient to describe gas exchange of 
both O2 and CO2 in “simpler” patients, as shown in cardiac surgery patients by 
Allerød et al. [125]. 
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Currently, INVENT uses a single set of penalty functions to calculate suggestions, 
regardless of patient type and clinical circumstances. Although the majority of 
changes in FiO2 have been appropriate and all have been safe, results in a few patients 
indicate that INVENT may be too prone to increase FiO2 from low levels when SaO2 
is sufficient (see patient illustrated with dots in Figure 16). It may be sufficient to 
remove this tendency by making ischemia penalties smaller at SaO2 above 0.97 or 
toxicity penalty a little higher at low FiO2 (see Figure 7). Alternatively a new set of 
penalties could be formulated for example for weaning patients. In all circumstances, 
a new set of penalties would be relevant for patients with severe chronic obstructive 
pulmonary disease, where the patient‟s normal levels of oxygenation may be reduced.    
 
Some additional modifications of INVENT are necessary before a prospective 
evaluation can be performed for the three settings. The current simple model of lung 
mechanics implemented in INVENT assumes a constant linear compliance relating 
tidal volume to the difference between peak pressure and PEEP. Changes in tidal 
volume can, however, affect lung status, e.g. increases in tidal volume may increase 
peak pressure potentially recruiting collapsed alveoli reducing shunt thereby leading 
to less accurate predictions using the gas exchange model. As described in the 
following section on PEEP advice, it is difficult to formulate a mathematical model of 
lung mechanics, which is able to describe lung mechanics of patients from clinical 
data. Therefore it may be necessary to resort to a trial and error approach as in rule-
based systems. This can be performed by implementing a step to target algorithm in 
INVENT such that large changes in tidal volume can be performed in steps and gas 
exchange can be evaluated at each step. Similarly increases in f may cause intrinsic 
PEEP. As such, the step to target functionality should include f, and end-expiratory 
occlusions should be performed allowing quantification of intrinsic PEEP.  
 
Advice on PEEP 
The large number of clinical trials which have failed at finding an optimal PEEP 
strategy in ALI/ARDS patients [e.g. 29,31,32] illustrate the need for better 
understanding of how PEEP should be managed. An important reason may be the lack 
of understanding of how changes in PEEP affect lung mechanics as well as gas 
exchange. Physiological models have been constructed to describe lung mechanics 
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either addressing specific components of the respiratory system in great detail [e.g. 
126] or the complete respiratory system using an empirical approach [127]. Whilst 
these models have added to the current understanding of lung mechanics they have 
not provided a fundamental understanding of the mechanical effects of changes in 
PEEP. In addition, attempts to link lung mechanics and gas exchange have been few 
[128], despite the fact that securing gas exchange is one of the goals of changes in 
PEEP.  
 
In order to enable model-based decision support of PEEP a novel model must be 
constructed, capable of explaining the effects of changes in PEEP. The model should 
be able to describe the effect of PEEP on both ventilation and perfusion, thereby 
allowing also description of gas exchange.  
 
To describe ventilation, the model should include the contributions of: the hydrostatic 
gradient down the lung due to the weight of the lung [4]; the chest wall; the lung 
tissue; and pulmonary surfactant. The chest wall and pulmonary surfactant have often 
been neglected in models of lung mechanics. The chest wall has been suggested as 
important in understanding recruitments maneuvers in ALI/ARDS patients [129]. 
Pulmonary surfactant is considered vital for mechanical stability during breathing 
[130], and inhibition of surfactant due to mechanical ventilation and edematous fluid 
entry indicate the importance of understanding surfactant to understand lung 
mechanics in respiratory disease [18]. Work has begun describing the different 
components in the healthy lungs [131], however future work is required addressing 
how the properties of the different components of the respiratory system change in 
respiratory disease. 
 
To the best of my knowledge, no mathematical models have been built to describe 
how changes in ventilatory pressures affect the distribution of pulmonary perfusion. 
We have begun building a model with this aim [132]. The model at its current state, 
describes the pulmonary perfusion in the healthy human lungs and is able to describe 
experimentally measured total capillary perfusion, volume and surface area [132]. 
Future work is required for describing pulmonary perfusion in respiratory diseases 
including addition of hypoxic pulmonary vasoconstriction, which acts to reduce 
pulmonary perfusion in hypoxic lung regions [133].  
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In addition to modeling the different components of the respiratory system, the 
heterogeneity of the lungs must be considered. A possible solution is to build 
stratified models allowing different layers to have different properties, e.g. due to 
different pleural pressures as caused by a hydrostatic gradient [4]. This may enable 
such models to describe the „baby-lung‟ of ARDS, that is, a very small volume of 
lung being ventilated due to the remaining lung being collapsed, or consolidated [5]. 
Models of lung mechanics have been built using a stratified structure including the 
model by Steimle et al. [127,128,131,134]. The model of perfusion introduced by 
Mogensen et al. [133] is based on the same stratified structure as the model by 
Steimle et al. [134], illustrating the possible combination of these models in the future 
to describe gas exchange and thereby also the link between lung mechanics and gas 
exchange. 
 
Alternatively to modeling the effects of changes in PEEP, one may derive simple 
algorithms describing compromises considering changes in FiO2 versus PEEP as done 
in clinical trials [e.g. 28]. However, changes in PEEP will likely impact the patient‟s 
gas exchange status and should as such be followed by a re-estimation of parameters 
of the gas exchange model. This may introduce the need for trial and error in some 
patients, similar to that necessary in rule-based systems. 
Clinical integration 
Whilst a DSS may provide sound advice, provide physiological understanding and in 
general improve patient care, it is of no value if it is not used at the bedside. An 
obvious way to enable successful clinical integration is through commercial 
collaboration with companies producing mechanical ventilators. This has been 
demonstrated with the GANESH system originally presented by Dojat et al. [49], 
which is now implemented as part of the SmartCare
TM
 system by Dräger Medical 
[64]. Besides performing several large studies demonstrating the efficiency of the 
system, as performed with GANESH [51-53], INVENT could benefit significantly 
from collaboration with the industry. However, as long as data can be retrieved from 
the ventilator, a system as INVENT could potentially be developed as a stand-alone 
system, albeit this would introduce significant obstacles, the main being that it would 
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be difficult if not impossible to make the system or parts of the system such as 
parameter estimation, closed loop. 
 
Morris described in 2000 several barriers to the use of computerized clinical 
protocols, i.e. rule-based DSSs [40]. The list presented by Morris included a lot of 
barriers concerning clinical culture and fear of losing authority. However, several 
barriers addressed qualities of the DSS, which would apply for an eventual integration 
of INVENT as well. These barriers can be translated to a few qualities a DSS should 
have: The system should not add more burdens to the already stressed critical care 
staff either in form of excessive data entry or high complexity; the system should be 
usable in a large variation of clinical cases not just the most prevalent; and the system 
should be supported by a technological infrastructure such as electronic patient 
records. 
 
As discussed previously the parameter estimation procedure used for estimating 
parameters of the gas exchange model in INVENT does not add considerable burden 
to the clinical staff, and it could potentially be automated. Further automation could 
include automatic detection of when new parameter estimation is necessary, e.g. after 
changes in settings or posture. When estimated, model parameters act to reduce 
complexity integrating data from various devices, and providing a physiological 
understanding of the patient directly related to changes in therapy. 
 
Paper III showed that INVENT could provide decision support of FiO2 in patients 
with different severities of lung disorder and in controlled as well as spontaneous 
ventilator modes. The current version of INVENT for providing suggestions of Vt and 
f is limited to volume controlled mode. Inclusion of more complex models of lung 
mechanics and respiratory drive would potentially allow INVENT to provide decision 
support in patients ventilated in pressure control mode as well as support ventilator 
modes. Models of respiratory drive have been built, which potentially could be used 
for such application [e.g. 135,136]. 
 
INVENT is implemented in the database system ICARE [118], which can facilitate 
automatic retrieval and storage of measurement data from several medical devices. In 
addition calculated values, estimated model parameters and INVENT advice can be 
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stored in the database, and values not automatically retrieved may be input manually. 
As such ICARE provides a technological infrastructure supporting all tasks related to 
using INVENT. Integration of ICARE with existing clinical databases would further 
strengthen this technological infrastructure, perhaps similar to the HELP database 
used in the successful Salt-Lake city protocols [45-48]. 
4.5 Model limitations 
A number of assumptions and simplifications have been made in the project regarding 
the use of minimal models to describe pulmonary gas exchange and when estimating 
model parameters. These are discussed in the following.  
 
All minimal models used in this PhD project have assumed continuous ventilation and 
perfusion, steady state, and that end-tidal gas and mixed alveolar gas fractions are 
equal. These assumptions do not represent the true nature of human breathing, which 
is tidal [137]. Models of gas exchange have been built describing tidal ventilation 
[e.g. 138,139]. However, estimation of model parameters for these models using 
clinical data has so far not been demonstrated, and the models have either been 
limited to simulations studies [138] or parameters have been estimated using a 
combination of MIGET and multiple breath nitrogen washout measurements [139]. 
As such, minimal models as those presented here, appear currently to represent the 
most accurate descriptions of gas exchange from clinical data. 
 
Effects of diffusion limitations have not been included in the models. Diffusion 
limitation has a similar effect on pulmonary gas exchange as A/QV causing a ΔPO2 
[140]. Studies with MIGET, however, has demonstrated that in the majority of 
patients, A/QV mismatch is likely a better description of physiology [93,93,140] 
except in cases of pulmonary fibrosis [93], exercise [141] or mild exercise during 
hypoxia [141,142]. 
 
The parameter estimation procedure depends on measurement of arterial oxygenation 
at steady state at varying levels of FiO2. This is done under the assumption, that 
varying FiO2 does not alter the physiology of the patient in such a way that 
A/QV mismatch and shunt are affected significantly. Variation in FiO2 may affect 
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lung physiology through absorption atelectasis and hypoxic pulmonary 
vasoconstriction (HPV). Absorption atelectasis is not likely to have an impact on 
parameter estimation, as it has been shown during induction of anaesthesia that 
absorption atelectasis mainly occurs at FiO2 levels of 0.8 or more [20], whilst 
parameter estimation rarely requires FiO2 levels as high as 0.8. HPV reported effects 
on gas exchange have been moderate [143] or considerable [144], but has represented 
maximal responses to changes in FiO2, the expected changes with the smaller 
variations in FiO2 being less likely to significantly affect pulmonary gas exchange. 
Studies with MIGET [145,146] and computer simulations [147,148] have also shown 
small changes in model parameters with large variations in FiO2. 
 
VDana and Q were assumed constant during the parameter estimation procedure, see 
section 2.2. In paper I, VDana and Q from the original papers were used [102-104]. In 
papers II and IV VDana was measured. In paper III, VDana including apparatus dead 
space was assumed to be 0.2 l in all patients. As VDana varies with posture, body size 
etc. [77], this simplification may have affected the correctness of estimated model 
parameters. However, it would have no consequence on INVENT suggestions of 
FiO2, as they would be based on model fits to measured FetO2-SpO2 curves and as 
such would reflect patient status as long as the model fitted data well.  
In papers II-IV, Q was either measured or estimated from body surface area and a 
population characteristic CI. This may likely not have reflected the true Q in some 
patients. However, a previous study with a two parameter model describing shunt and 
diffusion limitation, i.e. a ΔPO2, based on mass conservation and the same 
assumptions as models used in this project, showed that parameter estimation was 
insensitive to moderate variations in Q [106], with changes in Q of 40% changing fs 
by 0.04 and ΔPO2 by 0.5 kPa.    
4.6 Clinical perspectives 
The results presented in this thesis illustrate that a model-based DSS for mechanical 
ventilation may help to standardize therapy according to the individual patient. A 
model-based DSS may also help to diminish information overload, which if 
unattended affects clinical decision making [38,40]. INVENT uses a gas exchange 
model to integrate information from ventilator settings, hemodynamic parameters, 
oxygenation, acid base chemistry of blood and metabolism into two model 
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parameters, shunt and fA2 (ΔPO2) describing the gas exchange status of the patient. 
This can be valuable in the difficult to manage patients. In the easily managed 
patients, a model-based DSS as INVENT may free the focus of the clinicians on more 
challenging therapy.  
 
Results in papers I and IV illustrate that several measurements currently used in 
clinical practice are insufficient to provide an accurate description of pulmonary gas 
exchange in intensive care patients including ALI/ARDS patients. Results in paper I 
illustrated how the PaO2/FiO2 ratio varies with changes in FiO2 and SaO2. The 
PaO2/FiO2 ratio is the hypoxemia index used in the definition of ALI/ARDS and 
constitutes the single value separating ALI and ARDS diagnosis [1]. Paper I showed 
several patients changing disease classification due to variation in FiO2, a common 
therapeutical intervention normally not affecting pulmonary gas exchange. Other 
theoretical studies have come to similar conclusions but without involving clinically 
measured variations in the PaO2/FiO2 ratio [149-151].   
 
So how should the refractory hypoxemia evident in ALI/ARDS patients be defined? 
As suggested in paper I, at least the FiO2 level should be informed when using the 
PaO2/FiO2 ratio, however also SaO2 has an impact and would be appropriate to 
inform. However, standardizing FiO2 when including patients is unpractical and 
standardizing both FiO2 and SaO2 is even more so due to the varying severities of 
lung disorder seen in ALI/ARDS. Alternatively, minimal models of gas exchange 
could be used by estimating model parameters and classifying hypoxemia according 
to the levels of shunt and degree of A/QV  mismatch. The ability of the three 
parameter model to describe large fractions of shunt and large perfusions going to 
regions with low A/QV  ratios as shown in studies using MIGET indicate that the 
three parameter model may be suitable for this application. 
 
It has also been argued that a future hypoxemia index used in ALI/ARDS definition 
should not vary with changes in PEEP [152]. We disagree with this approach, as 
changes in PEEP, unlike most changes in FiO2, affect the pulmonary physiology 
[94,95] and may have different effects in different patients [37]. However, 
standardization of the level of PEEP used when evaluating patients could be very 
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relevant to potentially separate patients whose alveoli are readily recruited and where 
PEEP may keep these alveoli open from patients with consolidated lung regions. This 
is in line with several other authors advocating use of standardized ventilator settings 
when enrolling ALI/ARDS patients for clinical trials [153-154]. 
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5. General Conclusions 
 
1. A two parameter model of pulmonary gas exchange describing intrapulmonary 
shunt and ventilation-perfusion mismatch can describe variation in 
oxygenation with changes in FiO2. The shunt only model can not describe this 
variation accurately. 
2. The PaO2/FiO2 ratio varies significantly with FiO2 and its use as a hypoxemia 
index is questionable. As a minimum requirement measurements of PaO2/FiO2 
should be accompanied by the corresponding FiO2 level. 
3. The INVENT system provides appropriate suggestions of FiO2 and SaO2 in 
intensive care patients. 
4. Compared to attending clinicians INVENT standardizes the FiO2 levels and 
values of SaO2 according to the individual patient. 
5. All suggestions of FiO2 provided by INVENT results in safe values of SaO2. 
6. When identified, the two parameter gas exchange model describing shunt and 
ventilation-perfusion mismatch is capable of predicting the oxygenation 
response of intensive care patients to changes in inspired oxygen. 
7. A three parameter model is necessary for an accurate minimal model 
representation of the pulmonary gas exchange of both O2 and CO2 in intensive 
care patients. 
8. Estimation of model parameters for a three parameter model describing shunt 
and ventilation-perfusion mismatch may be performed using routine clinical 
data, potentially allowing this model to be used at the bedside in an ICU and 
as part of INVENT for providing advice on tidal volume and respiratory 
frequency.  
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Summary 
Mechanical ventilation is one of the key life-sustaining therapies applied in the 
intensive care unit. Management of mechanical ventilation is a complex task due to 
conflicting clinical goals. Decision support systems provide a tool for clinicians when 
selecting therapy by providing patient specific suggestions on therapy. This PhD 
thesis addresses the use of minimal models of pulmonary gas exchange, comparing 
models of varying complexity and clinically available measurements, and the use of a 
minimal model of O2 gas exchange in a decision support system to provide 
suggestions on inspired O2 in intensive care patients. 
 
The thesis describes the clinical and technical backgrounds of the project. Acute lung 
injury and acute respiratory distress syndrome (ALI/ARDS) are described constituting 
some of the most complex diseases with regards to mechanical ventilation, with lungs 
being susceptible to ventilator induced lung injury (VILI). Different VILI types are 
described as well as major clinical trials with lung protective ventilator strategies. The 
review illustrates that controversy exists and the optimal therapy for the individual 
patient remains elusive. Whilst volumes and pressures are the focus of current 
strategies, levels of inspired O2 are rightfully not ignored and minimized in the 
majority of trials. Decision support systems for mechanical ventilation are reviewed 
illustrating the predominate role of rule-based systems. Two inherent weaknesses of 
these systems are brought forward. Rule-based systems do not provide a deeper 
physiological understanding of the patient nor the provided advice, and may require 
trial and error to find appropriate therapy.  Model-based systems may solve both these 
problems using mathematical models with parameters having a physiological 
interpretation. Finally pulmonary gas exchange models are reviewed arguing that 
currently available measurements and models in clinical practice are oversimplified as 
they vary with therapies not affecting physiology. The reference technique for 
measuring gas exchange, the multiple inert gas elimination technique, is too complex 
for clinical application. Existing minimal models of pulmonary gas exchange 
represent compromises between complexity and feasibility.  
 
Four studies were carried out resulting in four corresponding papers forming the basis 
for this thesis. Models of different complexities were used, but all being based on 
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conservation of mass, continuous breathing and perfusion and assuming steady state. 
An existing model of the acid base chemistry of blood was implemented in the models 
to describe the gas exchange of both O2 and CO2. Parameter estimation methods were 
tailored to the varying aims and available data for the four studies. 
Paper I shows retrospectively that the predominant hypoxemia index, the PaO2/FiO2 
ratio, varies significantly with changes in inspired O2 in various patient groups 
including intensive care patients. A one parameter model describing intrapulmonary 
shunt can not describe this variation but a two parameter model describing shunt and 
ventilation/perfusion mismatch can. 
Paper II presents use of this two parameter model in the decision support system 
INVENT as part of a retrospective evaluation of INVENT in intensive care patients. 
INVENT provided appropriate suggestions of inspired O2 and model simulated levels 
of oxygenation in comparison to levels used in clinical practice. 
Paper III describes a prospective study comparing INVENT suggested levels of 
inspired O2 and resulting measured arterial oxygen saturation with levels selected by 
attending clinicians in an intensive care unit. INVENT provided appropriate 
suggestions on inspired O2 compared to attending clinicians.     
Paper IV describes a retrospective study of the necessary minimal model complexity 
to accurately describe pulmonary gas exchange of both O2 and CO2 in intensive care 
patients. A three parameter model was shown to be necessary. This model was able to 
describe perfusion of lung units with very low ventilation/perfusion ratios, a 
characteristic shown in ALI/ARDS patients using the multiple inert gas elimination 
technique. 
 
In conclusion, results presented in this thesis show that minimal models provide a 
more accurate description of gas exchange than measurements currently available in 
clinical practice. When used in a decision support system, minimal models also enable 
predictions of changes in oxygen saturation upon changes in inspired O2 fraction. The 
INVENT decision support system using a two parameter minimal model of O2 gas 
exchange provides appropriate suggestions on inspired O2 fraction in intensive care 
patients in comparison to attending clinicians, potentially standardizing care 
according to the individual patient. Inclusion of a three parameter minimal model of 
O2 and CO2 gas exchange may allow INVENT to provide appropriate suggestions on 
inspired O2, tidal volume and respiratory frequency. 
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Danish summary 
Mekanisk ventilation er en af de primære livreddende terapiformer i anvendelse på en 
intensivafdeling. Modstridende kliniske mål komplicerer indstilling af en respirator. 
Beslutningsstøttesystemer udgør et muligt værktøj til at hjælpe læger med valg af den 
mest hensigtsmæssige terapi. Denne PhD-afhandling omhandler brugen af minimal-
modeller af den pulmonære gasudveksling. Under projektet er minimal-modeller med 
forskellige grader af kompleksitet samt klinisk tilgængelige måleteknikker for 
evaluering af gasudveksling blevet sammenlignet, og en minimal-model af O2 
gasudveksling er blevet anvendt i et beslutningsstøttesystem til rådgivning om den 
inspirerede iltfraktion ved patienter på en intensivafdeling. 
 
Som udgangspunkt beskrives projektets kliniske og teknologiske baggrunde. Akut 
lungeskade og akut respiratorisk distress syndrome (ALI/ARDS) beskrives, idet de 
udgør komplekse former for respiratorisk svigt og patienterne er kendetegnet ved at 
være tilbøjelige til at udvikle respiratorinduceret lungeskade (ventilator induced lung 
injury - VILI). Der redegøres for forskellige VILI typer samt vigtige kliniske studier i 
strategier for mekanisk ventilation. Redegørelsen viser, at der er kontroverser omkring 
hvad VILI er, og hvordan strategier for mekanisk ventilation bedst muligt 
tilrettelægges for den individuelle patient. De fleste studier har fokus på volumen og 
tryk, men den inspirerede iltfraktion er med rette ikke blevet ignoreret og søges 
minimeret i størstedelen. En redegørelse for udviklingen indenfor 
beslutningsstøttesystemer gør det klart, at regel-baserede systemer dominerer. Der er 
dog to grundlæggende svagheder ved regel-baserede systemer. De giver ikke en 
forståelse for patientens fysiologi eller rådene de tilbyder, og de kan kræve, at man 
prøver sig frem for at finde den mest hensigtsmæssige terapi. Model-baserede 
systemer kan potentielt løse begge problemer ved brug af matematiske modeller med 
parametre tilknyttet en fysiologisk fortolkning. Til slut redegøres for matematiske 
modeller af den pulmonære gasudveksling. Her argumenteres for, at tilgængelige 
målinger af gasudveksling i klinisk praksis er for simple, idet de varierer med 
terapiændringer, der ikke påvirker patientens fysiologi. Referenceteknikken, the 
multiple inert gas elimination technique (MIGET) er for kompleks til klinisk brug. 
Minimal-modeller udgør et kompromis imellem kompleksitet og anvendelighed. 
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Afhandlingen er baseret på fire artikler. Minimal-modeller af forskellig kompleksitet 
er blevet anvendt, men alle er baseret på massebevarelse, kontinuert vejrtrækning og 
perfusion og antager ligevægtstilstand. En eksisterende model af blodets syre-base 
kemi blev implementeret i modellerne for at kunne beskrive gasudveksling af både O2 
og CO2. Metoder til parameterestimering blev tilpasset til tilgængelige data og de 
enkelte artiklers formål. 
Artikel I viser retrospektivt, at det dominerende hypoksæmi-index, PaO2/FiO2, 
varierer signifikant med ændringer i den inspirerede iltfraktion. En en-parameter 
model af intrapulmonær shunt kunne ikke beskrive denne variation i modsætning til 
en to-parameter minimal-model af shunt og ventilation/perfusions misforhold. 
Artikel II beskriver brug af den samme to-parameter model i 
beslutningsstøttesystemet INVENT, som blev retrospektivet evalueret i patienter på 
en intensivafdeling. INVENTs råd om inspireret iltfraktion og model-simulerede 
arterielle iltmætninger var hensigtsmæssige i sammenligning med klinisk praksis. 
Artikel III beskriver et prospektiv studie på en intensivafdeling, som sammenlignede 
INVENTs råd om inspireret iltfraktion og de målte resulterende arterielle 
iltmætninger med niveauer valgt af vagthavende læger. INVENTs råd var 
hensigtsmæssige i sammenligning med lægernes.  
Artikel IV beskriver en retrospektiv undersøgelse af den nødvendige minimal-model 
kompleksitet for at beskrive den pulmonære gasudveksling af både O2 og CO2 i 
patienter på en intensivafdeling. Studiet viste, at en tre-parameter model er nødvendig. 
Denne model kan beskrive perfusion af lungeenheder med meget lav 
ventilation/perfusions ratio, hvilket tidligere er beskrevet i ALI/ARDS patienter med 
MIGET. 
 
Resultaterne præsenteret i denne afhandling viser, at minimal-modeller giver en mere 
nøjagtig beskrivelse af gasudveksling end tilgængelige målinger i klinisk praksis. I 
beslutningsstøttesystemer kan disse modeller anvendes til at simulere ændring i 
arteriel iltmætning ved ændringer i inspireret iltfraktion. INVENT har ved brug af en 
minimal-model givet hensigtsmæssige råd om inspireret iltfraktion i forhold til 
vagthavende læger på en intensivafdeling. Potentielt kunne systemet standardisere, 
hvordan inspireret iltfraktion indstilles i forhold til den specifikke patient. Inklusion af 
en tre-parameter minimal-model kan muliggøre at INVENT i fremtiden også kan 
rådgive om tidalvolumen og respirationsfrekvens på en intensivafdeling. 
